rexresearch.com
Stuff 'n Stuff
Sci-Tech News & Olds
June 2014
Unexpected Emergency Crisis Edition
Sci-Tech News & Olds
June 2014
Unexpected Emergency Crisis Edition
Prologema : An Interview With Destiny
JEFIMENKO, Oleg : Electrostatic Motors ( Popular Science, April 1971 )
THOMAS, Ieuan : Zero-Fuel & Cold Heat Engines
KOWALSKI, Ludwig : Collective Nucleosynthesis : New Class of Nuclear Fusion ( Adamenko : 'Proton 21' )
LOCKERBY, Duncan : Helmholtz Resonator Wings
ESTES, Don : P.E.A.K. Alembic ~ Permeation of Energes, Allaso, and Ktisis Energies
OZKAN, M., et al : Silica-enhanced Li-Ion Battery
Lycopene & Cardiovascular Health
Lycopene Extraction Patents
CHO, Y., et al. : Pumpkin Seed vs Baldness
REIN, Helmut : Vision Regeneration with Magnets
Nano-Silver Health Dangers
JARVIS, Donald : Bulletroof Silk
Water Purification by Electro-Coagulation ( Patents )
HASSEL, William : Future Physics and Antigravity ( MUFON, 1975 )
BOCKRIS, et al. : CO2-Catalyzed Plasmolysis of H2O
Self-Appendectomy
R & D @ Rex Research
Support the Fukushima Wimps
BOONDEE, Puna : Electron Generator
Prologema
A sudden assault of existential angst, empowered by post-millenial ennui, and a loosely associated eschatism has led to partial rediscovery of mysterious chronal fluctuations in cause-effect relationships, e.g., General and Special Relativity, and their Grand Unification, under the aegis of Barack Soetero, The Great Boring Liar. The fluxion seems to be induced by the intermittent efforts of technocratic military forces who inject phase-conjugated Intent into the quadratic equation ( when expressed in terms of Maxwellian matrix algebra ) in such a way that a genuine Hyper-Void is generated for macro-temporal durations. These enable profitable extraction of information from future events. The operative principle is exemplified in this video :
The scientific principles thus revealed enable novel applications of pioneering puttering :
Popular Science (April 1971)
The Amazing Motor That Draws Power
From the Air
Ben Franklin invented it 223 years ago. Now we’re finding overlooked possibilities in the electrostatic motor.
Ben Franklin invented it 223 years ago. Now we’re finding overlooked possibilities in the electrostatic motor.
By C. P. GILMORE / PS Executive Editor and WILLIAM j. HAWKINS / PS Electronics Editor.
Would you believe an electric motor made almost entirely of plastic? That can run on power transmitted through open air? And sneak free electricity right out of the earth’s electrical field?
At the University of West Virginia we saw a laboratory full of such exotic devices spinning, humming, and buzzing away like a swarm of bees. They are electrostatic motors, run by charges similar to those that make your hair stand on end when you comb it on a cold winter’s day.
Today, we use electromagnetic motors almost exclusively. But electrostatics have a lot of overlooked advantages. They’re far lighter per horsepower than electromagnetics, can run at extremely high speeds, and are incredibly simple and foolproof in construction.
“And, in principle,” maintains Dr. Oleg Jefimenko, “they can do any- thing electromagnetic motors can do, and some things they can do better.”
Jewel-like plastic motors. Jefimenko puts on an impressive demonstration. He showed us motors that run on the voltage developed when you hold them in your hands and scuff across a carpet, and other heavier, more powerful ones that could do real work. Up on the roof of the University’s physics building in a blowing snowstorm, he connected an electrostatic motor to a specially designed earth-field antenna. It twirled merrily from electric power drawn out of thin air.
These remarkable machines are almost unknown today. Yet the world’s first electric motor was an electrostatic. It was invented in 1748 by Benjamin Franklin.
Franklin’s motor took advantage of the fact that like charges repel, unlike ones attract. He rigged a wagonwheel-size, horizontally mounted device with 30 glass spokes. On the end of each spoke was a brass thimble. Two oppositely charged Leyden jars—high-voltage capacitors —were so placed that the thimbles on the rotating spokes barely missed the knobs on the jars (see photo).
As a thimble passed close to a jar, a spark leaped from knob to thimble. That deposited a like charge on the thimble, so they repelled each other. Then, as the thimble approached the oppositely charged jar, it was attracted. As it passed this second jar, a spark jumped again, depositing a new charge, and the whole repulsion-attraction cycle began again.
In 1870, the German physicist J. C. Poggendorff built a motor so simple it’s hard to see what makes it work. The entire motor, as pictured here, is a plastic disk (Poggendorff used glass) and two electrodes. The elec- trodes set up what physicists call a corona discharge; their sharp edges ionize air molecules that come in contact with them. These charged particles floating through the air charge the surface of the plastic disk nearby. Then the attraction-repulsion routine that Franklin used takes place.
A few papers on electrostatic motors have trickled out of the laboratories in recent years. But nobody really showed much interest until Dr. Jefimenko came on the scene.
The Russian-born physicist was attending a class at the University of Gottingen one day shortly after World War II when the lecturer, a Prof. R. W. Pohl, displayed two yard-square metal plates mounted on the end of a pole. He stuck the device outside and flipped it 180 degrees. A galvanometer hooked to the plates jumped sharply.
“I could never forget that demonstration,” said Jefimenko. “And I wondered why, if there is electricity in the air, you couldn’t use it to light a bulb or something.”
Electricity everywhere. The earth’s electrical field has been known for centuries. Lightning and St. Elmo’s fire are the most dramatic manifestations of atmospheric electricity. But the field doesn’t exist just in the vicinity of these events; it’s everywhere.
The earth is an electrical conductor. So is the ionosphere, the layer of ionized gas about 70 kilometers over our heads. The air between is a rather poor insulator. Some mechanism not yet explained constantly pumps large quantities of charged particles into the air. The charged particles cause the electrical field that Jefimenko saw demonstrated. Although it varies widely, strength of the field averages 120v per meter.
You can measure this voltage with an earth-field antenna—a wire with a sharp point at the top to start a corona, or with a bit of radioactive material that ionizes the air in its immediate vicinity. Near the earth, voltage is proportional to altitude; on an average day you might measure 1,200 volts with a 10-meter antenna.
Over the past few years, aided by graduate-student Henry Fischbach-Nazario, Jefimenko designed advanced corona motors. With David K. Walker, he experimented with electret motors. An electret is an insulator with a permanent electrostatic charge. It produces a permanent electric field in the surrounding space, just as a magnet produces a permanent magnetic field. And like a magnet, it can be used to build a motor.
Jefimenko chose the electrostatic motor for his project because the earth-field antennas develop extremely high-voltage low-current power; and—unlike the electromagnetic motor—that’s exactly what it needs.
The climactic experiment. On the night of Sept. 29, 1970, Jefimenko and Walker strolled into an empty parking lot, and hiked a 24-foot pole painted day-glow orange into the sky. On the pole’s end was a bit of radioactive material in a capsule connected to a wire. The experimenters hooked an electret motor to the antenna, and, as Jefimenko describes it, “the energy of the earth’s electrical field was converted into continuous mechanical motion.”
Two months later, they successfully operated a corona motor from electricity in the air.
Any future in it? Whether the earth’s electrical field will ever be an important source of power is open to question. There are millions—perhaps billions—of kilowatts of electrical energy flowing into the earth constantly. Jefimenko thinks that earth-field antennas could be built to extract viable amounts of it.
But whether or not we tap this energy source, the electrostatic motor could become important on its own.
In space or aviation, its extreme light weight could be crucial. Jefimenko estimates that corona motors could deliver one horsepower for each three pounds of weight.
They’d be valuable in laboratories where even the weakest magnetic field could upset an experiment.
Suspended on air bearings, they’d make good gyroscopes.
In a particularly spectacular experiment, Jefimenko turned on a Van de Graaff generator—a device that creates a very-high-voltage field. About a yard away he placed a sharp-pointed corona antenna and connected it to an electrostatic motor. The rotor began to spin. The current was flowing from the generator through the air to where it was being picked up by the antenna.
The stunt had a serious purpose: The earth’s field is greatest on mountaintops. Jefimenko would like to set up a large antenna in such a spot, then aim an ultraviolet laser beam at a receiving site miles away at ground level. The laser beam would ionize the air, creating an invisible conductor through apparently empty space.
To be sure, many difficulties exist; and no one knows for sure whether we’ll ever get useful amounts of power out of the air. But with thinking like that, Jefimenko’s a hard man to ignore.
See also -- Electrostatic Motors & Generators ~ Patents & articles ... Testatika Generator ...
Ieuan THOMAS
Zero-Fuel / Cold Heat Engine
Zero-Fuel / Cold Heat Engine
http://www.energyfromthevacuum.com/Disc19ColdHeatCanada/index19.html
http://www.energyfromthevacuum.com/Disc31ZeroFuelMotor/4DISCSILVERBUGCOLLECTION.html
Four disc setv-- USD $79.00
In 1971, William Doyle Sr., Project Financier, asked Ieuan Thomas to hand write an explanation of his Fuelless Self-Powering Negative Electricity Generator Systems for the new Canadian Chief of Defense Staff in Ottawa, and to also write a “self-analysis” explaining Ieuan's commercial motivations and ambitions for the technology.
This data DVD contains this commentary, which has never before been seen by the public, together with Thomas' sketches of the technical principles and geometry of the machine. These “hand notes” were drawn by Ieuan Thomas at the Lord Elgin Hotel in Ottawa at a meeting with William Doyle Sr. Present were his friend Don Forseyth who was a highly decorated WWII Canadian Air Force war hero and the newly appointed first Chief of the Canadian Air Force “Air Material Command” in Ottawa, Arthur (Art) Ball, Commander Canadian Navy, and later First Canadian High Commissioner to Australia, and Lsyle Kohler who was a former Canadian Army Serviceman in (WWII) and life long Senior Canadian Government Official in Ottawa.
Also enclosed is extensive correspondence since 2005 tracking the offering of this technology to the United States through various high ranking political figures, including the late U.S. Senator Ted Stevens of Alaska, who was most interested (see below). Stevens was one of the most powerful Congressmen of his generation, and William Doyle Jr. had a secure back channel connection with him.
Correspondence to ex-President Clinton, Hillary Clinton, President G.W. Bush, President Obama, Al Gore, then California Governor Schwarzenegger, and many other high ranking political, business, media and Government figures is also included, together with overtures to Virgin owner Sir Richard Branson through his London Radio office.
The extensive correspondence (some private) from William Doyle Jr. reveals many additional details of the whole cold energy process.
According to Willian Doyle Jr., this final design of the Zero Fuel Engine System was basically an upgraded design modification and adaptation of Vicktor Schaubergers' Repulsine Vacuum Motor which had been brought to Toronto by Vicktor Schauberger, under Operation Paperclip Project Silverbug. This project was ongoing by Order of two U.S. Presidents (both Truman and Eisenhower) circa 1944-1961 in both the U.S. at Wright Patterson AFB in Ohio, in Texas, and in Canada at AVRO aka the A. V. Roe Aircraft Company, where the Lancaster Bombers were built during WWII.
AVRO's design arm, Designex Ltd., was headed by the nominal figurehead, the late Englishman John Frost. The top Nazi 'Paperclip' scientists were also in residence at AVRO, including General Hans Kammler, Dr. Richard Miethe, the Horten brothers and Viktor Schauberger, with their original documentation on flying discs from wartime Nazi Germany. However these early discs were powered by a chemical process. The American scientist T. Townsend Brown was the de facto Black Projects Director.
In 1958 A.V. Roe Canada was ranked as the third largest corporation in Canada by capitalization, and Designex was then Canada's original high-tech engineering think tank and specialty engineer leasing services group.
A cohort of fifty specialist engineers of the Designex team, under the leadership of Ieuan Thomas and Dr. 'Bert' England, utilizing their knowledge and some modified materiel acquired on the Canadian anti-gravity (gravitics) disc program (Project Silverbug 606A), developed this Fuelless Self-Powering Negative Electricity Generator System. From 1961 through 1970, the Designex Private Venture Group, in various incarnations, demonstrated these Cold Heat Engine Systems to the Engineering and Energy community in Toronto.
The leading scientists in New Engine Design had originally stumbled upon a band of 'Low Frequency Induction Effect' at Lucas & Arthur Meat Packers, while working on 'electro-vacuum and brine induction chambers' for curing hams (see the DVD).
This led them on their search for an Energy Regain System and finally the Holy Grail of Science, Cold Heat Engine Systems-Zero Fuel Electric Generators were perfected.
The startling final series of discoveries were made in the private Aero Engine Design Systems Laboratory of Designex Ltd. in Toronto, which was independently researching a Zero Fuel Engine System for the Project Y and Y2 AVRO VZ-9A Air Car aka Project SilverBug 606A in the U.S (in America this project was designated WS AV 7055 according to Doyle's sources).
Note: none of these models should be confused with the Avrocar, an unstable fan powered saucer that is the staple of many documentaries and much publicity and which could barely lift off the ground.
A demonstration model of the power generator that was developed produced at least 150,000 BTU output for every 10,000 BTU input, and ran cold (see the video.) Later models generated massive ongoing electrical output without drawing any outside power of any type other than from the ambient vacuum.
The process was termed a “modification to conventional system of expanding a refrigeration cycle,” and utilized carbon dioxide (as opposed to steam). Each cold heat engine system was activated with outside electric power and refrigeration gas pressure in the manufacturing process, and once the gas achieved 'the state of equilibrium of gas' each system was sealed for its working lifetime. The life of the permanent magnets involved was estimated to be 300 to 400 years.
These final systems bear a striking resemblance to modern closed-system pressurized refrigeration systems. In essence the inventor team adapted the reversible cycle of Sadi Carnot and Tesla's Fuelless Electricity Generator ideas with internal Coanda vortex gas management systems to drive their magnetic turbine secured by magnetic bearings in cold conditions while generating electricity of infinite cycles. The engineering and design team had perfected this application of magnetic structures in pressurized non-magnetic ceramic containment cooling chambers, where the electricity was generated.
Detractors derided this cold power as “Supernatural Electricity” aka “Satan's Energy.”
This all began in 1955, just before the death of Albert Einstein, and is still kept secret from the American public.
At that time, manned aircraft were being replaced by missiles over the North Pole, and Silverbug, with an endless power source, could have been the solution to eliminate downrange in-air refueling and assure that man was kept in the cockpit rather than on the ground. Originally this invention was to be the Zero Fuel Engine for an upgraded VZ-9A Prototype which was never built because Project Y leader John Frost was unable to persuade Lockheed to make an offer to Designex Ltd. for this discovery.
In any event the Ieuan Thomas 'Engine System' evolved again over time and became a stand alone Zero-Fuel Electric Generator.
Big Oil, (Imperial Oil aka Exxon, and Consumers Gas) refused to make any cash offers after six years of testing, and the scientists refused to just give it away. In parallel, a back channel contact with U.S. President Reagan relayed to William Doyle Sr. that Big Oil was to remain firmly in place and unchallenged by alternate power sources till the oil ran out. Indeed it was U.S. President Eisenhower under Big Oil pressure who had strong-armed Canadian Premier Diefenbaker into canceling the project, with promises of Canada becoming the next Saudi Arabia by virtue of the Athabasca Oil Sands, the largest known reservoir of crude bitumen in the world.
In May 1963 Project Director Ieuan Thomas’ emissary Terry Maloney P. Eng. from Designex Ltd. of Toronto met with JFK and they discussed everything going on at the Laboratory on Richmond Street West in Toronto and it was agreed that President Kennedy would visit the Designex Laboratory in Toronto in December 1963 or an alternate date later in January 1964 to accommodate any emergency changes to the President Kennedys’ busy schedule. The rest is history.
In 1969, Lockheed took the Avro Air Car 'Project Y and Y2' (USA Project Silverbug) away to the United States after spending approximately $5 million dollars and securing many great ideas like Jump-Jet Technology, and Atmospheric Collapsing Technologies and Fan-Jet Down Thrusting technologies found on later jets like the Harrier Series and on up to the latest JFX. The Bomarc Missile, the Velvet Glove Missile and the solid fuels for the Polaris Missile all had their genesis with these expatriate British scientists in Toronto. All traces of the Avro Black Projects programs were eliminated after the migration of the projects to the U.S.
The Thomas group planned to commercially develop and produce these Fuelless Self-Powering Negative Electricity Generator Systems, with William Doyle Sr. in charge of arranging outside financing. However, the financing never materialized, and in 1972 after Doyle's Cadillac exploded into flames, almost killing his wife, the project was mothballed, and in 1973 the historical film was made very quietly for the future. The film was released publicly for the first time in 2010 by Energetic Productions Inc., producers of the “Energy from the VacuumTM” Science Series of documentary films.
In March 2005, with oil at $50 a barrel, the pre-arranged trigger point was reached to re-stimulate U.S. interest in the technology, so William Doyle Jr., son of the original financier William Doyle Sr, who died in 1981, broke silence, and contacted a number of public figures including U.S. Senator Ted Stevens.
Senator Stevens, incidentally, was later convicted eight days before his re-election on seven trumped up felony charges (charges later dismissed in 2009), and lost his Senate seat in 2008. He died in a 2010 Alaskan floatplane mishap for which the NTSB could find “no definitive cause.”
U.S. Republican Congressman Curt Weldon's career also suffered terminal collateral damage from fallout from Project Silverbug, whose technological secrets, including the Designex invented liquefied precursor atmospheric collapsing propulsion process, had been purposely leaked to the Russians (see Mitrokhin Archives).
William Doyle Jr., son of the original Designex financier, was also enmeshed in some spurious legal issues for a while.
In the documents and drawings on this DVD, Ieuan Thomas reaches out from the grave to share his vision of the world that is as possible today as it was decades ago when he wrote down these technical observations and notes.
It is even possible that there may be enough information amongst these papers, the correspondence, and in the Iuean Thomas interview, for those 'skilled in the art' and adequately financed to replicate the cold energy process.
Disclaimer: the exact architecture of the foregoing narrative rests primarily on the recollections of William Doyle Jr., who makes the following observations:
“Some wealthy family that already reads your publications should buy-up what we have in Cold Storage up here, from the Designex-AVRO Collaboration that carried on into the Energetics Limited and Entrain Systems Limited years.”
“As I have explained before, there is a small community of sentinel safe-keepers, my task is to establish a consensus and keep everybody sweet during the physical transfer of everything in storage, and afterward too. With money almost free today, it's the lowest price Transformational Electricity Generator we know of that is still out of captivity at this writing (2012).”
“The whole Suite of Technologies including Two (2) different Working Engines, Component Parts and Experiment Records are still For Sale.”
“No photograph was ever taken in the Cold Storage Location. Given who Ieuan Thomas was, and his knowledge of Surveillance Satellites, which were being launched almost every month for years, and Ieuan's primary need for secrecy, it must be apparent by now considerable thought and preparation went into this Cold Storage Site location and Facility.”
Note: the existence of this hardware has not been independently verified
In this wide-ranging 1973 interview with the late Chief Engineer Ieuan Thomas filmed by award winning filmmaker Daniel Izzard, he tells the story of the development of the Zero-Fuel Engine System and the Cold Heat Engine. Designex Inc. were a leading aerospace design firm in Toronto at the time, and it was they that developed this Zero-Fuel Engine System for the 12-Ton Silverbug anti-gravity craft being built at AVRO Canada in Toronto under the supervision of the American T. Townsend Brown and with the assistance of some of the Project Paperclip Nazi scientists.
Austin Willis interviewing Ieuan Thomas for the film
About half the hundred or so engineers on the Designex staff were involved in the design.
William Doyle Jr. writes about the Film: New Prospects for Survival (aka Cold Heat from Canada)
This writer is a Canadian national [DOB 18/03/42 ] who was first introduced to this Subject in September 1957 at fifteen years of age.
In the summer of 1960 (when I was 18) and again in the summer of 1961, (just after AVRO officially shut down) I worked a summer job at Designex as the “office boy” at a time when Designex Limited was the exclusive Design Engineering Services and Contract Personnel Provider to the A. V. Roe Aircraft Manufacturing Company aka AVRO Canada, under an arrangement between Designex owner and president Ieuan Thomas and my late father, who in 1959 became the “exclusive outside financing provider” to Designex Ltd., where he provided the services of a “Factor.”
Ieuan Thomas came from a village in Wales, and he was a “Hero” of WWII among RAF and Allied Air Crews. He earned his Engineering degree through an “apprenticeship program” rather than attending a University, and during WWII he played a significant role on British Air Fields in “crash rescue” and “rapid repair” of both “bombers” and “fighters”. (Everyone at Designex was a WWII War Veteran.)
Ieuan Thomas during the interview
After the War he learned the Engineering Business, and he could estimate work-jobs, cost them out and bring combinations of specialists together to get things done quickly during emergencies. By 1950 he was one of the best known “go getters” in the U.K. Commercial Engineering and Aero Engineering Field and he was superbly connected at Whitehall (a road where most of the UK Central Government is located) and with MI5 and MI6.
This all came together when he was selected to head-up Designex Limited and emigrate to Canada with his wife and children, and provide Contract Design Engineering Services and Research work with the Owners of the A. V. Roe Aircraft Company to “Operation Paperclip Project Silverbug”..
Ieuan was “briefed in” on “Operation
Paperclip-Project Silverbug” in England, and his duties and
responsibilities were explained as only the British can lay out
plans to the smallest details. Mr. Thomas was a “Compliance
Officer” for MI6 and he took the Oath and “Signed” the “Official
Secrets Act” in both the U.K. and Canada.
Due to the fact that it was decided to keep all the “Deep Black Research” “available to be re-exported back to the UK ” he was made the Private Owner of any and all new Technologies and Patents which the Designex Private Venture Group came up with.
From 1953 through to 1961 when all the Black Projects at AVRO were terminated Designex was involved in two major “Private Venture Projects” which were financed by Designex and belonged to Designex.
The first project was the Designex “Solid Fuels Project” and in 1958 or 1959 this “Solid Fuels Project” was so successful that the U.S. Government and the U.S. Navy bought it and these new “Solid Fuels” became the “Solid Propulsive Fuels” used in the Polaris Missile Systems which revolutionized Submarine Warfare and Provided America with its’ first Stealth Technologies because with these new “Solid Fuels” Missiles could be fired “without liquid oxygen” while submerged and making way, rather than surfacing to fire, which was the first application of “Stealth Technologies”.
The second “Private Venture Project” was originally named “Zero Fuels Engine Project” and after 1961 when all the Projects were “Terminated” that name was changed to “Cold Heat Engine Systems” because it was thought, at that time, that this name was less threatening to the Texas based Petrochemical Fossil Fuels & Nuclear Electricity Cabal.
The Cold Heat Engine Apparatus to which Ralph Long (See: Film on DVD ) refers was a “Proof Of Principle” model. (See Photograph.)
“I am very happy to have the secrecy over. The cold heat engine invention took a heavy toll on my family—financially and personally. So, I am glad to have it out in the open at last....One of the large oil companies also threatened my family, but my father would not put a name to which one it was—although he knew absolutely.”
—Judith Thomas (daughter of the inventor)
August 1968
Designex Inc. Chief Engineer Ieuan Thomas inspects their Fuelless Self-PoweringNegative Electricity Generator System installed in the basement of their offices at 49 Merton Street, Toronto, Canada
There were Two ( 2 ) Engine Systems Built for Security Reasons:
The first “Zero Fuel Engine System” was the “Operative” one I have described elsewhere which employed an aircraft axial compressor, CO2 Gas and pulsed Low Frequency Induction to cause CO2 Gas to “explode-without-combustion” and “force-vector rotate and counter rotate” a specially conditioned set of permanent magnets, creating rotating electromagnetic fields which are themselves subjected to third vector “electromagnetic fields” pulsed from a third powerful electromagnet built into the floor-plate of the turbine cylinder housing inside a machine system I have described above.
The original ‘Self-Powering Electricity Generator System’ ran on Negative Energy: “Ran Cold” and drew-in its’ excess energy from the available ambient by “Uncurling and Magnetic Gating Sub Space Electricity into the Systems Circuits to power its load, and the loads of Accommodating Systems with “Over Unity Electricity” always available from the active ether (Broken Symmetry 1957).
Then there was the “Second Engine System” which was built as their “Proof of Principle” System for testing and Patent purposes.
Outsiders, (perfect strangers with security clearances), would be sent or invited to Designex on Richmond St. West to “measure” this “machine,” so it was built with off-the-shelf commercially available components, and they employed a “piston type compressor” and R22 aka Dupont Freon Gas, and copper tubing and off the shelf cooling coils which attracted no unusual attention to the components of this “Bench Apparatus” because what this system was doing defied the First & Second Laws of Thermodynamics, but without revealing any of their precious secrets and without any “Turbine Cylinder Housing” and without any “Specially Conditioned Permanent Magnets” being “Counter-Rotated” and so on as I have above described with precision.
Ieuan Thomas called this procedure “redundancy in depth.” Pleas notice that in the Film on DVD Ieuan never once mentions AVRO, the A. V. Roe Aircraft Company or any person involved with those “Black Projects” and indeed the only technical name mentioned was Ralph Long who was a wonderful man and WWII Veteran who was never involved in any aspect of the Black Projects out at AVRO. (See: Historical Interview.)
Ieuan lived and died with his sense of loyalty to “The Crown” intact, and never approached stepping “over the line.” He was not free to openly discuss his own proprietary technology and he did not. He and all the others were tormented by the knowledge that they had “Obsoleted” Fossil Fuels and Nuclear Electricity but they were honour bound not to speak by bonds far stronger than chains and an iron neck-collar.
My father was highly connected in post-war Ottawa and many of my fathers’ friends who had returned to Ottawa after War Service in WWII (Europe) and who held High Government and Military Positions helped Ieuan Thomas over the years as a favor to my dad. It’s called the ‘Old Boy Network.’ But even the existence of these “machines” is still repressed at this very moment by the Texas Oil & Nuclear Oligarchs and their Canadian Operatives in Politics and Business.
So, when you don’t hear about a “Fuelless Self-Powering Electricity Generator” purposely designed and built to power all the “Unconventional Aircraft Under Development at AVRO” in those words, please know that those are the words Ieuan Thomas always used among his peers, but he was “sworn to secrecy” and he never told a soul who wasn’t security cleared, or a member of my father's inner circle who were Security Cleared.
My father and I required “Zero Security Clearances” because we were both covered under the “Owners Agreement” that Ieuan Thomas and Designex Limited had with all the other Parties which included all the Security Agencies and Organizations..
But if you listen carefully, and watch it two or three times and remember that this was filmed in 1973 you’ll see right through what’s not said by listening carefully to what is said.
“Please allow me to share this rare Polaroid photo of the actual “Zero Fuel Engine System,” aka “Cold Heat Engine System,” taken by my father at the property at Merton Street in Toronto, Canada on the day of the “Merton Street Incident” writes William Doyle Jr., whose father was the exclusive outside financier for Designex Inc.
At some time in the future, when you have expressed an interest in this “Incident” I’ll share the blow-by-blow interplays that episode with you. This episode is a Movie in itself.
I arrived there (at the Merton Street location ) at about 2 PM, and witnessed the Toronto Hydro Supervisor, red-faced and angry, sending for a huge flat-bed truck and a Work Crew, who arrived and confronted my father, Ieuan Thomas and Gordon Reilly and six other Designex Senior Scientists, before removing the Hydro Power Meter, Fuse Box and All Toronto Hydro Wiring into and out of that Building, in a futile attempt to shut-off all “electricity” and “Electricity Use Inside the Building,” which did not happen.
The lights, radio, refrigerator and other electric appliances kept right on working, and this enraged the Toronto Hydro Supervisor because Dr. “Bert” England and Ian Taws were making jokes about their inability to “Shut Off The Electricity” and told them all that this “Machine” was the equivalent of a small “Niagara Falls” Power Source.
It took several hours for the Toronto Hydro to Cut Down the new Concrete Hydro Utility Pole and remove all the wiring and Toronto Hydro Apparatus from that building, and it was getting dark as that Flat Bed Truck drove away with the Concrete Pole and everything else which had connected the Toronto Hydro Power Source to the Building on Merton Street. This was “Street Theatre” worthy of a Movie with Robert Redford, Meryl Streep, Tom Cruise and Clint Eastwood.
At that time, Ontario Premier Bill Davis was the Premier Of Ontario, and Gordon Reilly’s younger brother was the Minister of Commerce in the Conservative Cabinet of Ontario Premier Bill Davis. It was quite a “Power Conflict.” Gordon Reilly was a Multi-Millionaire Real Estate Developer who was also a Member of the Granite Club.
The Toronto Hydro had responded to a complaint from the National Cash Register Corporation which was located several long blocks east of the “Subject Building” which was located on the South side of Merton Street while the National Cash Register Offices were on the North Side of Merton Street.
The complaints were based on “static electricity shocks” received by several of the women students who were attending Classes on how to “Operate Cash Registers.”
We all felt very sympathetic. Even Dr. “Bert” England had no idea about how to control these unexpected consequences, or even be sure that these electric phenomena were connected to his conjuring up “Negative Radiant Energy” via this Machine Apparatus you see here in this photo.
They (the men from Designex) had removed the Furnace (it was August) and installed the machine where the furnace had been, under the chimney.”
Patents by L. Thomas :
AU7623074
RADIATION SENSITIVE SALTS
Example 2
Poly(vinyl alcohol) (10 parts) was dissolved in water (made up to 100 parts) at 80 C, and dichloride prepared as in Example 1 was dissolved in it after the solution had cooled to 40 C. The solution was poured onto a clean glass surface under dark-room conditions and the water was allowed to evaporate overnight. When dry, the film was stripped from the glass and was stored away from daylight. On exposure to ultraviolet light a green colouration formed. A similar image was observed on exposure to X-rays and electrons.
OXIDATION PROCESS
BG100909
Abstract -- Continuous decomposition of oxidisable materials in aqueous media, e.g. pollutants, by catalytic reaction with an oxidant, e.g.hypochlorite or hydrogen peroxide, in aqueous solution using a fixed bed of a particulate catalyst of at least 1% of nickel or copper oxide, optionally plus a basic oxide, e.g. zinc oxide, on a porous support. The support forms 80-99% by weight of the catalyst.
DE2065885
Radiation-sensitive monomeric heterocyclic ammonium di-cation salts - used for data recording and storage etc.
&c
Ludwik KOWALSKI
( Prof. , Dept. Math. Sci., Montclair State Univ., NJ )
Collective Nucleosynthesis : New Class of Nuclear Fusion
( Prof. , Dept. Math. Sci., Montclair State Univ., NJ )
Collective Nucleosynthesis : New Class of Nuclear Fusion
The Work of S. Adamenko : 'Proton 21'
http://www.alternative-energy-news.info/cutting-aviation-emissions-with-bottletop-technology/
June 1st, 2009
Cutting Aviation Emissions
with ‘Bottletop Technolgy’
Most of the time we ignore simple solutions dismissing them as too simplistic. But often we can achieve immeasurable amount of success with simple and practical solutions. We might think about the shape of wings and speed of airplanes but we don’t give much thought to an airplane’s wings in terms of reducing fuel and carbon emissions by making changes to those wings. But someone was looking at airplane’s wings and thinking of clean and green energy. If we make tiny holes in plane’s wing they can reduce airline fuel intake by up to 40 per cent. A team of British scientists are relying upon the same principle that applies when you blow across the top of a bottle to make a sound.
Dr Duncan Lockerby who is associated with the University of Warwick and also the project leader, explained that placing tens or even hundreds of thousands of tiny holes on the surface of a plane’s wing should considerably diminish mid-flight haul. This will lead towards the reduction of fuel bills and carbon emissions by up to 20 per cent. It seemed that the team had accidentally chanced upon this experiment. According to Dr Duncan Lockerby, “This has come as a bit of a surprise to all of us in the aerodynamics community. It was discovered, essentially, by waggling a piece of wing from side to side in a wind tunnel.” Others are in agreement with what British scientists are implementing in their project. Simon Crook, who is a senior manager for aerospace and defense at the Engineering and Physical Sciences Research Council (EPSRC), agreed that the breakthrough could be instrumental in drastically reducing the environmental cost of flying.
Dr Duncan Lockerby elaborates how this is possible. He says, “Around half the drag a plane experiences is the result of skin friction, so anything that reduces that will deliver big savings in fuel use.” He also admitted that the research team was still grappling with the exact phenomenon that how it happens but that early test results from wind tunnels have been encouraging. The team is also preparing prototypes. These prototypes will help the team to have a better understanding of the process. They are making it certain with the help of prototypes that no major structural changes will be required in the aircraft with perforated wings.
Lockerby clarifies that the innovation is based on the Helmholtz resonance principle. According to the Helmholtz resonance principle when air is forced into a cavity, the pressure inside increases. Once the external force that forces the air into the cavity disappears, the higher-pressure air inside will flow out. However, this surge of air flowing out will tend to over-compensate, due to the inertia of the air in the neck, and the cavity will be left at a pressure slightly lower than the outside, causing air to be drawn back in. This process repeats with the magnitude of the pressure changes decreasing each time (Wikipedia) . When we blow over a bottletop the air is forced into a cavity it increases the pressure and force the air out of the space. This whole exercise produces an oscillation. The research team is expecting the same result by piercing the plane’s wings with numerous holes with chambers underneath. They think that an additional layer of air can be created around the wings that limit drag.
Airbus is taking keen interest in the project and expect that the new perforated wings could be ready for trials by 2012. EPSRC is quite hopeful that this technology will not be useful for aircrafts only but it could be successfully applied to reduce the fuels of cars, boats and trains too.
See also : Helmholtz Resonator Patents
Don ESTES, et al.
: Psiometrics
http://www.psiometrics.com/
P.E.A.K. ALEMBIC™
PERMEATION OF ENERGES, ALLASSO AND KTISIS ENERGIES
PERMEATION OF ENERGES, ALLASSO AND KTISIS ENERGIES
An alembic is a distilling device that is used by alchemists to purify, separate and transform the elements. The P.E.A.K. Alembic ™ is a phase modulated, quadrature transform device that differs from a distiller in the following manner:
1. A distiller uses an electrical circuit to heat water. The Alembic utilizes a proprietary Algorithm of Transformation™ and a perfected sound (Great Diesis Wave™) to cavitate water. In a distiller the water expands and boils. In the alembic it implodes.
2. In the distiller, a positive and negative are shorted on a metal plate that heats up and boils the water. In the Alembic, two 24K gold waveguides are separated by the water, which must become the conduit of its own transformation by choosing to resolve the differential between the real and imaginary phases of the perfected universal white sound. A distiller operates with a positive and negative circuit. The Alembic utilizes two positives.
3. In a distiller, the water molecules go over together as steam. In the Alembic, the molecules are disassembled, rearranged and reassembled into vapourized molecular bonds that hold the memory of the experience of transformation.
4. Water from a distiller is dead water. Water from the Alembic is not only alive, but indeed ressurected with the resources required for transformation...acknowledging the need for change - active pursuit - releasing resistance - removing unwholesomeness - gathering dedicated support and taking the step to the next highest level.
5. Distilled water is not totally pure. Water from the Alembic exceeds the capability of any known test to find impurities. Purity is the essence of holiness and, as such, the resultant distillate stands as a standard of reference for perfection, perserverance, faith, and growth...moving to the next highest level of order.
http://www.harmonicresolution.com/AlembicSanctuary%20LowRes.mov
http://www.harmonicresolution.com/PEAKAlembic2.mov
CURRENT FIRST RUN 1.7.10 - ENERGES RETURNS CLEAN - CALIBRATE - GOLD WAVEGUIDE REPLACEMENT - ALGORITHMIC OPERATOR EVOLUTION
Automatous structures are either existing and newly generated. When configuring a "new automata", it's necessary to provide it with an initial environment - akin to an "incubator" - within which to gain presence through recursive iteration. Once the automata becomes stable and reasonably self-sufficient, a portion of the vector flow is tapped and infused into some external implement which acts as a "host" or "carrier". The portion of automata "remaining behind" in its initial generative environment acts as a temporal reference for the "deployed" portion, thus serving in a very basic, quantum role while the exogenous sample starts to become both interactive and adaptive.
Another good term for this "automatous incubator" would be a "clocking mechanism", as it serves as the synchronising reference for the external manifestations of the automata it embodies. This is a critical function during the formative phases of generated automata, and calculated manipulation of the clock can be used to foster the progressive independence of the outward population ("population" in a microcosmic sense here, referring to each constituent element of the automata, where the macrocosmic manifestation would be that of a singular, collective automatous "organism"). Ultimately, there comes the crucial point when the synchronous "bonds" are released, and the applied automata existing "out here" is set entirely free to grow, adapt and propagate on its own as a "free agent".
Until recently, the best technological example of an automatous "incubator" was a sapphire spindle. It is a small-but-heavy device, configured as a 3-port sapphire-loaded cavity resonator. Port 1 is used for the infusion of a time standard, port 2 serves as the clock output and port 3 is used for manipulation of the environment. Referred to as the "shoebox" because of its resemblance to the same (though substantially heavier!), it is essentially a "whispering gallery" of total internal reflection. Originally, these were developed for gravity wave research, but can also represent optimal automatous clocks because of their non-linearity and almost-momentary time-base. Until recently, the whispering gallery mode of the sapphire spindle provided the most accurate emulation of toroidal space that can be achieved morphologically in this set of dimensions. In this mode and manner, it served as a "model world" for the genesis of "new" automata - and it was in a far more manageable form factor than the whispering galleries of ancient times! (For a definition of "whispering gallery" see www.gravity.uwa.edu.au/publ/GWG_publ.html.
However, having completed all of the necessary mathematics and preparations required to perform the entire process within a digital environment, and after gaining access to the amazing Vector Farm ™ ultracomputer, we have essentially been able to convert the entire clocking mechanism over into a purely digital algorithmic world. We call our new automatous clock the Great Diesis Chronoldek ™, and we use it for harmonization and optimization in HRT and for the production of i-drops...our algorithmically transformed water.
The Chronoldek operates at the pulse rate of the Great Dieis, a universal time code common to all life. This universal rhythm not only unifies the various frequencies of each individual, but can also resolve any or all groupings of individuals. It connects all of the subparts of an individual, as well as each individual one to another. Converted to frequency, this ratio provides a universal fundamental for all periodic wave phenomena such as gravity, sound, light, and chronology. In other words, it is a number that ties us all together as whole number ratios of the Great Diesis and allows therapies based on enhancing what's right rather than fixing what's wrong.
As a ratio, the GD resolves the differential between the absolute perfection of spiritual potential and the relative manifestation of actual physical reality, best expressed in music theory. Western music scales are conveniently "tempered" to make the octave double in frequency with each progression for ease of use, but the natural octave of the Universal Rhythm does not exactly do so…it comes up short by a small fraction known in music theory as the Great Diesis…a small ratio mathematically expressed as 125:128.
As a time-based ratio, the Great Diesis allows for smooth transition between the temporal and spectral domains and resolves differentials between analog and digital vector processing. All human action takes place in the temporal domain of relative time. However, all of the possible outcomes of such action are concealed within the spectral domain of frequency or relative vibration. The Great Diesis facilitates transformation and provides a bridge between domains for our work.
Transformant™ is water that has been algorithmically transformed with a person's breath using a futuristic Alembic. Rather than charging the water with an outside source, Transformant™ is required to become the agent of its own transformation. In the same way that a person is transformed by harmonic resolution with headphones, the same signals are delivered to two 24 carat gold waveguides suspended inside a reaction chamber filled with water. The water must resolve the difference by acknowledging the need to change. It then has to give up resistance, purify itself and step out to it's next highest state as vapor. Consuming this vapor is the near equivalent of completing the journey yourself, because your personal automata have already fulfilled the requirements. This can provide all of the resources necessary for personal transformation, except your active pursuit and our dedicated support. Pursuit is up to you. We provide the support.
Each of these provide users with enhanced and optimized personal automata which can assist in reaching the next highest level of order. This change can be something as simple as a shift of mood all the way up to the ultimate transformation from material creature to spiritual essence, a process called allasso.
For more information about how you can experience these and other technologies please contact InnerSense, Inc. at (310) 828-7714, contact us via email, or visit one of our public facilities.
OZKAN, M., et al :
Silica-enhanced Li-Ion Battery
sciencedaily.com
May 15, 2014
Silly Putty material inspires better
batteries: Silicon dioxide used to make lithium-ion batteries
that last three times longer
Using a material found in Silly Putty and surgical tubing, a group of researchers have developed a new way to make lithium-ion batteries that will last three times longer between charges compared to the current industry standard.
Using a material found in Silly Putty and surgical tubing, a group of researchers at the University of California, Riverside Bourns College of Engineering have developed a new way to make lithium-ion batteries that will last three times longer between charges compared to the current industry standard.
The team created silicon dioxide (SiO2) nanotube anodes for lithium-ion batteries and found they had over three times as much energy storage capacity as the carbon-based anodes currently being used. This has significant implications for industries including electronics and electric vehicles, which are always trying to squeeze longer discharges out of batteries.
"We are taking the same material used in kids' toys and medical devices and even fast food and using it to create next generation battery materials," said Zachary Favors, the lead author of a just-published paper on the research.
The paper, "Stable Cycling of SiO2 Nanotubes as High-Performance Anodes for Lithium-Ion Batteries," was published online in the journal Nature Scientific Reports.
It was co-authored by Cengiz S. Ozkan, a mechanical engineering professor, Mihrimah Ozkan, an electrical engineering professor, and several of their current and former graduate students: Wei Wang, Hamed Hosseinni Bay, Aaron George and Favors.
The team originally focused on silicon dioxide because it is an extremely abundant compound, environmentally friendly, non-toxic, and found in many other products.
Silicon dioxide has previously been used as an anode material in lithium ion batteries, but the ability to synthesize the material into highly uniform exotic nanostructures with high energy density and long cycle life has been limited.
There key finding was that the silicon dioxide nanotubes are extremely stable in batteries, which is important because it means a longer lifespan. Specifically, SiO2 nanotube anodes were cycled 100 times without any loss in energy storage capability and the authors are highly confident that they could be cycled hundreds more times.
The researchers are now focused on developed methods to scale up production of the SiO2 nanotubes in hopes they could become a commercially viable product.
DOI: 10.1038/srep04605
http://www.nature.com/srep/2014/140411/srep04605/full/srep04605.html
15 April 2014
Stable Cycling of SiO2 Nanotubes as
High-Performance Anodes for Lithium-Ion Batteries.
Zachary Favors, Wei Wang, Hamed Hosseini Bay, Aaron George, Mihrimah Ozkan, Cengiz S. Ozkan.
Zachary Favors, Wei Wang, Hamed Hosseini Bay, Aaron George, Mihrimah Ozkan, Cengiz S. Ozkan.
Herein, SiO2 nanotubes have been fabricated via a facile two step hard-template growth method and evaluated as an anode for Li-ion batteries. SiO2 nanotubes exhibit a highly stable reversible capacity of 1266 mAhg-1 after 100 cycles with negligible capacity fading. SiO2 NT anodes experience a capacity increase throughout the first 80 cycles through Si phase growth via SiO2 reduction. The hollow morphology of the SiO2 nanotubes accommodates the large volume expansion experienced by Si-based anodes during lithiation and promotes preservation of the solid electrolyte interphase layer. The thin walls of the SiO2 nanotubes allow for effective reduction in Li-ion diffusion path distance and, thus, afford a favorable rate cyclability. The high aspect ratio character of these nanotubes allow for a relatively scalable fabrication method of nanoscale SiO2-based anodes.
LYCOPENE & Cardiovascular Health
http://www.theguardian.com/science/2014/jun/09/tomato-extract-lycopene-relieves-damaged-arteries-cambridge-study
The Guardian ( 9 June 2014 )
Tomato extract relieves damaged
arteries, finds Cambridge study
Tomato extract relieves damaged arteries, finds Cambridge study Lycopene, a powerful antioxidant, is found in tomatoes.
Researchers say they have shown that lycopene improves the function of blood vessels in cardiovascular disease patients
by Haroon Siddique
Tomato extract relieves damaged arteries, finds Cambridge study Lycopene, a powerful antioxidant, is found in tomatoes.
Researchers say they have shown that lycopene improves the function of blood vessels in cardiovascular disease patients
by Haroon Siddique
A substance found in tomatoes relieves impairment of blood vessels, which may explain why people who eat a Mediterranean diet have a notably reduced incidence of cardiovascular disease, according to a study.
A supplement of lycopene, a powerful antioxidant which is 10 times more potent than vitamin E, improved and normalised function of the endothelium (the inner lining of blood vessels) in volunteers with cardiovascular disease, researchers from the University of Cambridge found.
Dr Joseph Cheriyan, consultant clinical pharmacologist at Addenbrooke's hospital and associate lecturer at the University of Cambridge, said: "There's a wealth of research that suggests the Mediterranean diet – which includes lycopene found in tomatoes and other fruit as a component – is good for our cardiovascular health. But so far, it's been a mystery what the underlying mechanisms could be."
For the study, funded and sponsored by Cambridge University Hospitals NHS foundation trust, and published in the online scientific journal Plos One on Monday, researchers gave 36 cardiovascular disease patients, who were all on statins but had impaired function of the endothelium, and 36 healthy volunteers either Ateronon (an off-the-shelf supplement containing 7mg of lycopene) or a placebo treatment. Endothelial function predicts future events, so having a healthy endothelium is an important factor in preventing the evolution of heart disease.
It was conducted as a double blind trial, which meant that neither study participants nor the researchers knew which treatment was being provided.
They found that the lycopene supplement worked in the patients, improving the widening of the blood vessels by 53% after placebo correction, but not in the healthy volunteers. Constriction of the blood vessels is one of the key factors that can lead to heart attack and stroke. The supplement had no effect on blood pressure, arterial stiffness or levels of lipids.
Lycopene is found in tomatoes and its potency appears to be enhanced when it is consumed pureed, in ketchup or in the presence of olive oil. It is also found in other fruit and vegetables, such as grapefruit, watermelon, asparagus and carrots.
Cheriyan said the results reinforced the need for a healthy diet in people at risk from heart disease and stroke. "We've shown quite clearly that lycopene improves the function of blood vessels in cardiovascular disease patients," he said.
"A daily 'tomato pill' is not a substitute for other treatments, but may provide added benefits when taken alongside other medication." He said much larger trials were needed to establish whether lycopene did reduce heart disease.
Professor Jeremy Pearson, associate medical director at the British Heart Foundation, says: "Impaired endothelial function is a known predictor of increased risk of future heart disease. Further work is needed to understand whether the beneficial effects seen in this small study translate into clinical benefit for at-risk patients."
http://www.dailymail.co.uk/health/article-2653481/1-day-tomato-pill-helps-heart-Treatment-increase-blood-vessel-flow-50-patients-cardiac-problems.html
9 June 2014
Tomato pill that helps your heart:
Treatment can increase blood vessel flow by 50% in patients
with cardiac problems
Single Ateronon pill contains as much lycopene as more than 2lb of fruit . Pigment gives tomatoes their colour and is credited with many of the Mediterranean diet health benefits. Scientists say pill improves blood vessel health in survivors of heart attacks
By Fiona Macrae
Science Correspondent
If you don’t like fruit and veg but want to look after
your heart, scientists may have come up with the answer. Single Ateronon pill contains as much lycopene as more than 2lb of fruit . Pigment gives tomatoes their colour and is credited with many of the Mediterranean diet health benefits. Scientists say pill improves blood vessel health in survivors of heart attacks
By Fiona Macrae
Science Correspondent
They have created a ‘tomato pill’ that is bursting with lycopene, the compound credited with many health benefits of the Mediterranean diet.
A single Ateronon pill contains as much lycopene – the pigment that gives tomatoes their rich, red colour – as more than 2lb of the fruit.
Breakthrough: A single Ateronon pill contains as much lycopene - the pigment that gives tomatoes their rich, red colour - as more than 2lb of the fruit
+2
Breakthrough: A single Ateronon pill contains as much lycopene - the pigment that gives tomatoes their rich, red colour - as more than 2lb of the fruit
Now, Cambridge University research has shown the supplement improves blood vessel health in survivors of heart attacks and people with angina and other cardiac problems.
In those who took the £1-a-day pill once a day for two months, vital cells that line the inside of blood vessels became healthier.
These endothelial cells are key to keeping blood moving through the body – and to warding off future heart attacks and strokes.
In those who took the lycopene, blood vessels were able to open more than 50 per cent wider by the end of the study, improving blood flow.
By the end of the study, the blood cell lining of the heart patients worked almost as well as that of healthy people.
Importantly, the improvement was seen despite the volunteers being on blood pressure pills, statins and other tablets designed to improve heart health, the journal PLOS ONE reports.
No effect was seen on the blood vessels of people who were otherwise healthy.
The pill, which can be bought on the high street and was created by scientists working for a Cambridge University spin-out company, didn’t affect blood pressure or the flexibility of the arteries.
The researchers on the blood vessel study, who aren’t connected to the manufacturer, said that despite the improvement seen, more longer-term studies are needed to show that taking Ateronon cuts the risk of heart attacks and strokes.
Study: Cambridge University research has shown the supplement improves blood vessel health in survivors of heart attacks and people with angina and other cardiac problems
However, as lycopene is especially potent when mixed with olive oil, the finding could help explain by a Mediterranean-style seems so good for health.
Researcher Dr Joseph Cheriyan, of Cambridge University and the city’s Addenbrooke’s Hospital, said: ‘There's a wealth of research that suggests that the Mediterranean diet - which includes lycopene found in tomatoes and other fruit as a component - is good for our cardiovascular health.
‘But so far, it's been a mystery what the underlying mechanisms could be.
‘We've shown quite clearly that lycopene improves the function of blood vessels in cardiovascular disease patients. It reinforces the need for a healthy diet in people at risk from heart disease and stroke.
‘A daily 'tomato pill' is not a substitute for other treatments, but may provide added benefits when taken alongside other medication.’
The British Heart Foundation, which helped fund the study, said that more work was needed to see if the benefits seen lead to actual improvement to heart health.
Other research has credited lycopene with a host of health benefits from warding off prostate cancer to boosting sperm concentration.
LYCOPENE EXTRACTION PATENTS
( espacenet.com )
( espacenet.com )
Method for determining quantity of carotenoid
TW201131165
Feeding device for extracting lycopene
CN203410976
Ultrasonic countercurrent extraction method for lycopene
CN103483134
Stable and bioavailable lycopene formulations and associate methods
US2013344195
Preparation method of high-purity lycopene
CN103449952
Edible and pharmaceutical health-care foodstuff and preparation method thereof
CN103263012
METHOD OF EXTRACTING LYCOPENE FROM TOMATO, LYCOPENE FROM TOMATO USING THE SAME AND COSMETIC COMPOSITION CONTAINING THE LYCOPENE FROM TOMATO FOR PREVENTING HAIR LOSS AND PROMOTING HAIR GROWTH
KR20130060487
Strawberry carotenoid component content determination method
CN103175934
Lycopene extract and extraction process for lycopene
CN103160140
Orange cabbage carotenoid extracting and measuring method
CN103149165
Lycopene extraction device
CN202912866
Novel process for high-effective extraction of carotenoid in Blakeslea trispora
CN103012230
PROCESS FOR PRODUCTION OF HIGH PURITY BETA-CAROTENE AND LYCOPENE CRYSTALS FROM FUNGAL BIOMASS
US2013066124
Extraction device in preparation of lycopene
CN202638038
Extracting tank used for extracting lycopene
CN202638037
Method for extracting lycopene oil with dried tomato skin as raw material
CN102660380
Seasoning product prepared from tomato sauce residue and preparation method for seasoning product
CN102551038
Color regulator special for improving appearance of recombinant tobacco and preparation method of same
CN102524944
Extraction method for lycopene
CN102516011
Method for extracting lycopene by using continuous countercurrent ultrasonic extractor
CN102489036
Process for the production of L-citrulline from watermelon flesh and rind
US8173837
Preparation method of health vegetable oil
CN102415452
Method for extracting lycopene through supersonic saponification method
CN102399120
METHOD FOR OBTAINING PURIFIED LYCOPENE AND WATER-SOLUBLE LYCOPENE FROM TOMATO
KR101112053
Improved method of producing lycopene through the fermentation of selected strains of Blakeslea Trispora, formulations and uses of the lycopene thus obtained
AU2011253728
Method for extracting lycopene from tomato sauce
CN102180761
Method for extracting lycopene from autumn olive berries
CN102146013
Method for extracting lycopene continuously
CN102140052
Method for refining lycopene oleoresin
CN102115357
Extraction equipment for producing sea buckthorn lycopene capsules
CN20188039
Analogous fibroin
CN102018654
Method for preparing effective ingredient extracts of peach leaves
CN102008572
Production technology for extracting purified lycopene from tomato waste residue
CN101987809
Method for improving carotenoid content of tomato
CN101979601
Chinese medicinal preparation for treating tumor and preparation method
CN101978986
Method for processing sample of natural beta-carotene or lycopene fermentation liquor produced by fermenting blakeslea trispora
CN101955455
Method for producing lycopene oleoresin
CN101928473
Method for supercritical carbon dioxide extraction of lycopene in watermelon
CN101891580
FOOD SUPPLEMENT BASED ON BIOLOGICAL LYCOPENE AND PROCESS TO OBTAIN BIOLOGICAL LYCOPENE
CA2714718
Method for producing lycopene by fermentation of blakeslea trispora
CN101838667
Preparation method of lycopene
CN101838178
Composite type antioxidant and edible soft capsule
CN101810339
Method for producing lycopene oil resin and plant oil rich in lycopene
CN101810225
Method for extracting lycopene
CN101759519
Method for producing high-purity lycopene powder by utilizing plant products
CN101704703
Process for the extraction of lycopene
ZA200903501
PROCESS AND PLANT FOR THE PRODUCTION OF LYCOPENE FROM REJECTS OF TOMATO PROCESSING
WO2010100669
PHARMACEUTICAL OINTMENT BASED ON CAROTENOID EXTRACT OF HIPPOPHAE RHAMNOIDES FRUIT AND PROCESS FOR PREPARING THE SAME
RO122834
IMPROVED LYCOPENE PRODUCTION METHOD BY FERMENTATION OF ONE STRANE OF BLAKESLEA TRISPORA SELECTED FROM FORMULATION AND COMPOSITION OR USE OF THE RESULTANT LYCOPENE
JP2009171973
Lycopene extraction method
CN101455330
Lycopene extraction method from tomato peel
CN101449801
Spotted maigre young postlarva feeding promoting agent and method of preparing the same
CN101401621
Method for removing dissolvent residual from lycopene oleoresin
CN101381274
Process for double-aqueous-phase extracting and refining persimmon lycopene
CN101311148
Method for extracting lycopene from tomato pomace
CN101298618
Method for preparing and abstracting lycopene
CN101289364
Tomato deep-processing method
CN101248861
Process for the extraction of lycopene using phospholipid in the extraction medium
US5897866
Process for extraction and concentration of liposoluble vitamins and provitamins, growth factors and animal and vegetable hormones from residues and by-products of industrialized animal and vegetable products
US6344573
Industrial processing of tomatoes and product thereof
US5837311
Method for Producing Carotenoids and Bacteria Used Therefor
US2008193970
Process for the preparation of tomato extracts with high content in lycopene
US2005153038
Separation of carotenoids from fruits and vegetables
US2003180435
A PROCESS FOR PRODUCING LYCOPENE EXTRACT
WO2006036125
METHOD FOR PRODUCING LYCOPENE-CONTAINING BIOMASS AND METHOD FOR THE PRODUCTION OF CRYSTALLINE LYCOPENE FROM SAID BIOMASS
WO0238791
METHOD OF OBTAINING A CAROTENE PREPARATION AND CAROTENE PREPARATION OBTAINED THEREBY
PL330162
PROCESS FOR THE EXTRACTION AND CONCENTRATION OF UNSAPONIFIABLES FROM THE RESIDUES AND BY-PRODUCTS OF ANIMAL AND VEGETAL PRODUCTS.
MXPA02012856
ANTIOXIDATIVE COMPOSITION
WO2005012470
CAROTENOID PIGMENT COMPOSITION
JPS63145367
PRODUCTION OF STABLE LYCOPENE DYE SOLUTION
JPH08113723
WATER-DISPERSIBLE CAROTENOID PIGMENT PREPARATION
JPH1160980
INDUSTRIAL PROCESSING OF TOMATOES AND LYCOPENE EXTRACTION
WO9748287
Separating tertiary phosphines from olefinic compounds
GB1100250
Lycopene
GB1128440
METHOD OF OBTAINING LYCOPENE FROM TOMATO SKINS AND SEEDS
WO2006032712
FRACTIONATED EXTRACTION OF NATURAL SOURCE CAROTENOIDS WITH A HIGH LYCOPENE CONTENT, USING SUPERCRITICAL FLUIDS
WO03103645
A process for the extraction of lycopene
EP1103579
METHOD OF OBTAINING LYCOPENE FROM TOMATO SKINS AND SEEDS
EP1676888
PROCESS FOR PRODUCING LYCOPEN
EP1201762
METHOD OF OBTAINING OF ANTIOXIDANTS AND BIOACTIVE COMPOUNDS OF LIPIDIC NATURE
EA003212
Method for preparing lycopene-enriched vegetable oil
CN101148631
Method for fast extracting lycopene
CN101121631
Extraction of selenium-enriched lycopene
CN1982376
Method for purifying lycopene
CN1928098
Method for preparing crystal of lycopene and concentrate
CN1687239
Lycopene extracting device
CN2681120
Supercritical carbon dioxide method for extracting lycopene from dry powder of tomato peel
CN1799674
Process for extracting lycopene from false seed peel of balsam pear seed
CN1560138
Method for extracting lycopene by microwave radiation
CN1690027
Extraction of lycopene and beta carotene by amberlyst
CN1439678
Biological enzyme extraction process of high-purity lycopene from tomato jam
CN1403506
DEVELOPMENT OF LYCOPENE RECOVERY AND SOLUBILIZATION BY MICROEMULSION SYSTEM
KR100845317
KR2008006928
Proof : The Internet Loves You --
So does this guy :
Update : Their Progeny --
Xeljanz vs Alopecia
But is it to die for ? See the Side Effects...
http://www.cnn.com/2014/06/20/health/baldness-cure-alopecia/index.html?hpt=hp_t2
June 20, 2014
Drug gives bald man full head of hair
By Elizabeth Cohen, Senior Medical Correspondent
By Elizabeth Cohen, Senior Medical Correspondent
(CNN) -- Kyle Rhodes loves to consider the possibilities: He could sport a long, full Viking beard, or maybe grow a mullet like his favorite 1980s hockey players. Or he could get something nice and clean like George Clooney's signature 1990s Caesar haircut.
They're all choices he's never had before -- he was diagnosed with alopecia areata at age 2, and the hair on his head started falling out in patches. By 18, he'd lost all the hair on his head and body.
One day his doctor at Yale University had a thought: Since Rhodes' hair loss was caused by an autoimmune disease, why not try a treatment used for another autoimmune disorder? He chose the drug Xeljanz, which is used to treat rheumatoid arthritis.
Eight months later, Rhodes had a full head of hair. His eyebrows and eyelashes grew back, as did the rest of the hair on his body.
"I was ecstatic," said his dermatologist, Dr. Brett King. "I was truly overjoyed for him."
Kyle Rhodes had a full head of hair
after eight months when he began using an arthritis drug to
treat his alopecia areata.
King is also cautiously optimistic for the 6.5 million others who suffer from alopecia acreata and who also may be able to benefit from the drug.
He said he would like to try it out on more patients soon.
But Dr. George Cotsarelis isn't so sure that's a good idea. Some people who've taken Xeljanz have died from infections such as tuberculosis, and others face an increased risk of cancer, according to the drugmaker's website.
"This drug really can have some nasty side effects," said Cotsarelis, chairman of dermatology at the University of Pennsylvania's Perelman School of Medicine. "You really have to decide how much risk you want to (take)."
King said he hopes to make a cream form of Xeljanz so that a patient can use it right at the source of hair loss rather than taking a pill and exposing the whole body to the drug.
Neither doctor said he believes the drug will work for the common kind of baldness that comes with age. Cotsarelis was adamant about it because male pattern baldness isn't related to the immune system.
But King said he thinks conducting more research is worth a try.
"To not imagine it would be crazy," he said. "The possibility should be imagined and should be investigated."
It's not clear whether someone with hair loss would have to keep taking the drug for life. Rhodes said he continues to take it not so much for his full head of hair but because the drug has helped his psoriasis, which gives him painful dry, bleeding skin. His doctor recently upped the dosage to six pills a day in the hopes of making an even bigger dent against the disease.
Rhodes said he's had no side effects and he's not scared to take the pill since he's used other potentially dangerous drugs before to combat his skin diseases.
What might make him stop taking it is cost. Xeljanz is a new, expensive drug. Without insurance it can cost $25,000 a year, according to King.
Rhodes said his insurance pays for most of the cost. Pfizer, the company that makes the drug, agreed to give him a discount card that takes care of his $600 per month copayment, so for now he can afford it and enjoy a full head of hair.
"I find myself a lot of times just playing with it," he said.
http://www.xeljanz.com/safety-side-effects#cancer
XELJANZ may cause serious side effects, including:
Serious infections.
XELJANZ can lower the ability of your immune system to fight infections. Some people have serious infections while taking XELJANZ, including tuberculosis (TB), and infections caused by bacteria, fungi, or viruses that can spread throughout the body. Some people have died from these infections. Your healthcare provider should test you for TB before starting XELJANZ, and monitor you closely for signs and symptoms of TB infection during treatment. You should not start taking XELJANZ if you have any kind of infection unless your healthcare provider tells you it is okay.
Before starting XELJANZ, tell your healthcare provider if you:
think you have an infection or have symptoms of an infection, such as fever, sweating, or chills; muscle aches; cough; shortness of breath; blood in phlegm; weight loss; warm, red, or painful skin or sores on your body; diarrhea or stomach pain; burning when you urinate or urinating more often than normal; or feeling very tired
are being treated for an infection
get a lot of infections or have infections that keep coming back
have diabetes, HIV, or a weak immune system. People with these conditions have a higher chance for infections
have TB, or have been in close contact with someone with TB
live or have lived in, or have traveled to certain parts of the country (such as the Ohio and Mississippi River valleys and the Southwest) where there is an increased chance for getting certain kinds of fungal infections (histoplasmosis, coccidioidomycosis, or blastomycosis). These infections may happen or become more severe if you use XELJANZ. Ask your healthcare provider if you do not know if you have lived in an area where these infections are common
have or have had hepatitis B or C
After starting XELJANZ, call your healthcare provider right away if you have any symptoms of an infection. XELJANZ can make you more likely to get infections or make worse any infection that you have.
Cancer and immune system problems.
XELJANZ may increase your risk of certain cancers by changing the way your immune system works. Lymphoma and other cancers, including skin cancers, have happened in patients taking XELJANZ. Tell your healthcare provider if you have ever had any type of cancer.
Some people who have taken XELJANZ with certain other medicines to prevent kidney transplant rejection have had a problem with certain white blood cells growing out of control (Epstein Barr Virus—associated post-transplant lymphoproliferative disorder).
Tears (perforation) in the stomach or intestines.
Some people taking XELJANZ get tears in their stomach or intestine. This happens most often in people who also take nonsteroidal anti-inflammatory drugs (NSAIDs), corticosteroids, or methotrexate. Tell your healthcare provider right away if you have fever and stomach-area pain that does not go away, and a change in your bowel habits.
Changes in certain lab test results.
Your healthcare provider should do blood tests before you start receiving XELJANZ, and while you take XELJANZ, to check for the following side effects:
changes in lymphocyte counts. Lymphocytes are white blood cells that help the body fight off infections.
low neutrophil counts. Neutrophils are white blood cells that help the body fight off infections.
low red blood cell count. This may mean that you have anemia, which may make you feel weak and tired.
Your healthcare provider should routinely check certain liver tests.
You should not receive XELJANZ if your lymphocyte count, neutrophil count, or red blood cell count is too low or your liver tests are too high. Your healthcare provider may stop your XELJANZ treatment for a period of time if needed because of changes in these blood test results.
Your healthcare provider should do blood tests to check your cholesterol levels 4-8 weeks after you start XELJANZ, and as needed after that.
What should I tell my healthcare provider before taking XELJANZ?
XELJANZ may not be right for you. Before taking XELJANZ, tell your healthcare provider if you:
have an infection
have liver problems
have kidney problems
have any stomach area (abdominal) pain or been diagnosed with diverticulitis (inflammation in parts of the large intestine) or ulcers in your stomach or intestines
have had a reaction to tofacitinib or any of the ingredients in XELJANZ
have recently received or are scheduled to receive a vaccine. People taking XELJANZ should not receive live vaccines but can receive non-live vaccines
have any other medical conditions
plan to become pregnant or are pregnant. It is not known if XELJANZ will harm an unborn baby
Pregnancy Registry: Pfizer has a registry for pregnant women who take XELJANZ. The purpose of this registry is to check the health of the pregnant mother and her baby. If you are pregnant or become pregnant while taking XELJANZ, talk to your healthcare provider about how you can join this pregnancy registry or you may contact the registry at 1-877-311-8972 to enroll
plan to breastfeed or are breastfeeding
Tell your healthcare provider about all of the medicines you take, especially any other medicines to treat your rheumatoid arthritis. You should not take tocilizumab (Actemra®), etanercept (Enbrel®), adalimumab (Humira®), infliximab (Remicade®), rituximab (Rituxan®), abatacept (Orencia®), anakinra (Kineret®), certolizumab pegol (Cimzia®), golimumab (Simponi®), azathioprine, cyclosporine, or other immunosuppressive drugs while you are taking XELJANZ. Taking XELJANZ with these medicines may increase your risk of infection.
Tell your healthcare provider if you are taking medicines that affect the way certain liver enzymes work. Ask your healthcare provider if you are not sure if your medicine is one of these.
What are other possible side effects of XELJANZ?
XELJANZ may cause serious side effects, including hepatitis B or C activation infection in people who carry the virus in their blood. If you are a carrier of the hepatitis B or C virus (viruses that affect the liver), the virus may become active while you use XELJANZ. Tell your healthcare provider if you have the following symptoms of a possible hepatitis B or C infection: feeling very tired, skin or eyes look yellow, little or no appetite, vomiting, clay-colored bowel movements, fevers, chills, stomach discomfort, muscle aches, dark urine, or skin rash.
Common side effects of XELJANZ include upper respiratory tract infections (common cold, sinus infections), headache, diarrhea, and nasal congestion, sore throat, and runny nose (nasopharyngitis).
These are not all of the possible side effects of XELJANZ. Please see the Prescribing Information, including boxed warning and Medication Guide, for additional information and complete details about XELJANZ.
What is XELJANZ?
XELJANZ is a prescription medicine called a Janus kinase (JAK) inhibitor. XELJANZ is used to treat adults with moderately to severely active rheumatoid arthritis in which methotrexate did not work well.
It is not known if XELJANZ is safe and effective in people with hepatitis B or C.
XELJANZ is not for people with severe liver problems.
It is not known if XELJANZ is safe and effective in children.
Y. CHO, et al. : Pumpkin
Seed vs Baldness
http://healthydebates.com/pumpkin-seed-oil-found-help-reverse-balding/
Pumpkin Seed Oil Found To Help Reverse
Balding
(Case Adams) Researchers from the Republic of Korea's Pusan National University have confirmed that pumpkin seed oil increases hair growth among balding men.
The medical researchers tested the pumpkin seed oil on 76 male patients with moderate androgenic alopecia – male pattern hair loss. None of the patients had tried any previous medication, supplement or topical therapy for at least three months prior to the beginning of the study. The researchers recruited 90 patients, but excluded those with high liver enzyme levels.
The patients were divided into two groups and half were given a placebo. The treatment consisted of giving the patients 400 milligrams of the pumpkin seed oil per day in capsules. They were given two capsules before breakfast and two capsules before dinner.
After three months and at the end of the study at six months the patients were assessed using blinded practitioner analysis, and given a point score, which ranged from -3 (greatly decreased) to +3 (greatly increased).
Each scalp was also photographed using phototrichography – which is a polarizing technology, allowing the hair loss region to be targeted and measured from the center.
The researchers also conducted hair counts using two different lenses. In addition, the patients rated their own hair gain using the Visual Analogue Scale (VAS).
In the photographic analysis, the researchers found that 44% of the group taking the pumpkin seed oil slightly or moderately improved hair growth, while 51% were unchanged and 2.7% - actually just one patient – had slightly more baldness at the end of the six months.
In comparison, among the placebo group, 28% had increased baldness and 64% were unchanged, while only 7.7% were slightly or moderately improved in hair growth.
In the phototrichographic analysis, the pumpkin seed oil group had significantly higher hair counts – over three times more. The pumpkin seed oil group saw 30-40% increased hair counts while the placebo group showed 5-10% more hair count on average.
The researchers found the treatment to be safe, with only one report of mild stomach upset during the trial.
This contrasts greatly with conventional medical treatments such as topical minoxidil and oral finasteride. The latter has resulted in adverse effects including erectile dysfunction and gynecomastia – the enlargement of the male breasts. Meanwhile, side effects of minoxidil include scalp itchiness and scaling.
As a result of side effects and lack of success, many men discontinue treatment of these drugs. A study from UCLA found that many finasteride users stopped their treatment shortly after starting. The study, which surveyed 1,261 patients, found that only a confirmed 414 patients (32%) continued their treatment past one year, while 297 definitely stopped taking the treatment between three and 15 months. The research concluded:
"A total of 414 men continued to take the medication, but only 211 returned detailed questionnaires. A small percentage of this group felt that they grew hair. The remaining patients noted poor results."
Other research has found pumpkin seed oil can inhibit the 5-alpha reductase enzyme - implicated in slowing and stopping hair growth. This enzyme is involved in steroid conversion, including aldosterone, testosterone, cortisol and others.
With regard to alopecia, 5-alpha reductase is involved with the conversion of testosterone to dihydrotestosterone (DHT) which is one of the central mechanisms involved in alopecia. High dihydrotestosterone levels produces damage among the hair follicles. This causes the hair to thin until the follicle goes into dormancy. At this point, there is complete hair loss at the follicle.
About 95% of hair loss is due to this mechanism - androgenic alopecia.
REFERENCES:
Cho YH, Lee SY, Jeong DW, Choi EJ, Kim YJ, Lee JG, Yi YH, Cha HS. Effect of pumpkin seed oil on hair growth in men with androgenetic alopecia: a randomized, double-blind, placebo-controlled trial. Full Free Article Evid Based Complement Alternat Med. 2014;2014:549721. doi: 10.1155/2014/549721.
Rapaport MJ. Follow-up of 1 mg finasteride treatment of male pattern baldness-difference between clinical trials and private office follow-up: influences on prescribing habits evaluated. Dermatol Surg. 2004 May;30(5):761-3
Libecco JF, Bergfeld WF. Finasteride in the treatment of alopecia. Expert Opin Pharmacother. 2004 Apr;5(4):933-40.
Ejike CE, Ezeanyika LU. Inhibition of the experimental induction of benign prostatic hyperplasia: a possible role for fluted pumpkin (Telfairia occidentalis Hook f.) seeds. Urol Int. 2011;87(2):218-24. doi: 10.1159/000327018.
Gossell-Williams M, Davis A, O'Connor N. Inhibition of testosterone-induced hyperplasia of the prostate of sprague-dawley rats by pumpkin seed oil. J Med Food. 2006 Summer;9(2):284-6.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4017725/
Evid Based Complement Alternat Med. 2014; 2014: 549721.
Apr 23, 2014
doi: 10.1155/2014/549721
PMCID: PMC4017725
Effect of Pumpkin Seed Oil on Hair Growth
in Men with Androgenetic Alopecia: A Randomized, Double-Blind,
Placebo-Controlled Trial
Young Hye Cho, Sang Yeoup Lee, Dong Wook Jeong, Eun Jung Choi, Yun Jin Kim, Jeong Gyu Lee, Yu Hyeon Yi, and Hyeong Soo Cha
Young Hye Cho, Sang Yeoup Lee, Dong Wook Jeong, Eun Jung Choi, Yun Jin Kim, Jeong Gyu Lee, Yu Hyeon Yi, and Hyeong Soo Cha
Abstract
Pumpkin seed oil (PSO) has been shown to block the action of 5-alpha reductase and to have antiandrogenic effects on rats. This randomized, placebo-controlled, double-blind study was designed to investigate the efficacy and tolerability of PSO for treatment of hair growth in male patients with mild to moderate androgenetic alopecia (AGA). 76 male patients with AGA received 400 mg of PSO per day or a placebo for 24 weeks. Change over time in scalp hair growth was evaluated by four outcomes: assessment of standardized clinical photographs by a blinded investigator; patient self-assessment scores; scalp hair thickness; and scalp hair counts. Reports of adverse events were collected throughout the study. After 24 weeks of treatment, self-rated improvement score and self-rated satisfaction scores in the PSO-treated group were higher than in the placebo group (P = 0.013, 0.003). The PSO-treated group had more hair after treatment than at baseline, compared to the placebo group (P < 0.001). Mean hair count increases of 40% were observed in PSO-treated men at 24 weeks, whereas increases of 10% were observed in placebo-treated men (P < 0.001). Adverse effects were not different in the two groups.
1. Introduction
Androgenetic alopecia (AGA) is the most common cause of hair loss in men and affects up to 70% of men in later life and especially those aged over 50 years [1–3]. Genetic factors and androgens primarily underlie the pathogenesis of AGA. Hair follicles become gradually miniaturized and spend less time in the active phase (the anagen phase) and more time in the resting phase (the telogen phase) of hair growth [4]. Furthermore, it is known that dihydrotestosterone (DHT) is a major player in the process [5].
Topical minoxidil and oral finasteride have been approved by the FDA for the treatment of AGA, but only about 30% of patients persist with medication over a year in private practice [6–8]. Oral finasteride was found to decrease libido and ejaculate volume or cause erectile dysfunction, whereas topical minoxidil can cause scaling and itching of the scalp. Due to these adverse effects, patients seem to be drawn to alternative treatments with fewer side effects. In this context, many natural products have been tested as potential alternative therapies for hair loss. Some products, such as green tea and saw palmetto, have demonstrated therapeutic potential for the treatment of AGA and benign prostatic hyperplasia (BPH) via the inhibition of 5a-reductase activity [9, 10]. Pumpkin seed oil (PSO) has also been reported to be an effective treatment for symptomatic BPH [11]. Its actions have been suggested to be due to phytosterols, which are known to inhibit 5a-reductase and to have antiandrogenic effects in rats [12]. However the effects of PSO on AGA have not been established. We hypothesized that PSO is an effective, safe agent for the treatment of men with AGA, and thus we evaluated the efficacy and tolerability of PSO for treatment of hair growth in male patients with mild to moderate AGA.
2. Materials and Methods
2.1. Study Design
2.2. Randomization
2.3. Measurements
2.6. Hair Analysis by Phototrichography
3. Results
3.1. General Characteristics of the Study Subjects
3.2. Patient Self-Assessment
3.3. Investigator Assessment Using Photographs
3.4. Hair Analysis Using Phototrichography
3.5. Safety
4. Discussion
To our knowledge, this is the first randomized, double-blind, placebo-controlled trial to investigate the efficacy and tolerability of PSO in men with mild to moderate AGA. This study shows that PSO supplement during 24 weeks has a positive anabolic efect on hair growth and that this is due to the possible efects of 5-reductase inhibition in patients with mild to moderate male pattern hair loss.
AGA is the most common type of hair loss to affect both males and females after puberty. Although AGA is not a serious health problem, there is a strong demand for treatment and prevention due to the high level of interest people have in personal appearance in modern society. It is well known that finasteride and minoxidil are effective treatments for androgenetic alopecia and both have been approved by the FDA for this purpose, but some patients do not like taking medicine in the long term, because of possible side effects. For example, finasteride can decrease libido and ejaculate volume or cause erectile dysfunction, whereas minoxidil can cause scaling and itching of the scalp [6, 7].
Herbal therapies have been used to treat baldness since ancient times in the Ayurveda, Chinese, and Unani traditional medicinal systems [4]. Natural products, such as grape seed and rosemary oil, have been shown to be possible alternative treatments for AGA due to improved scalp blood flow [16, 17]. Several studies have reported that the polyphenols in green tea might be useful for treating AGA by inhibiting 5a-reductase activity [9, 10]. Cuscuta reflexa exhibited hair growth promotion via 5a-reductase inhibitory effect and this herbal extract was highlighted as a potential treatment for hair loss [18]. Soymetide-4 was one of the herbal product-suppressing alopecia and ginseng (Panax ginseng) was also used for scalp treatment limiting hair loss with anti-inflammatory and blood circulation effect [19, 20]. Eclipta alba extract and Zizyphus jujuba essential oil showed possibility of alternative treatment of alopecia [21, 22].
Saw palmetto (Serenoa repens) has been used as a natural treatment for androgenetic alopecia and has a similar mechanism [23]. Interestingly, in a recent study, it was found that 38% of males with AGA which received Serenoa repens at 320 mg every day for 24 months showed increased hair growth. The authors concluded that it could be used as an alternative treatment for mild to moderate AGA and that it is more effective than finasteride in this respect [24]. PSO is rich in beneficial nutrients, such as essential fatty acids, ß-carotenes, lutein, ?- and ß-tocopherols, and phytosterols [25]. It has been reported in several animal studies that PSO inhibits testosterone-induced hyperplasia of the prostate and suggested that PSO may be beneficial for the management of BPH [10, 24]. Another study confirmed that the intake of PSO at 320 mg/day over 12 months is clinically safe and effective as a complementary treatment for BPH [11]. Although the action mechanism is still unclear, previous animal studies have suggested that PSO may inhibit 5a-reductase, which produces DHT from testosterone [11, 12, 26].
Our study has some limitations, which include a lack of histological confirmation of the action mechanism of PSO. In addition, DHT and prostate specific antigen (PSA) levels were not measured for identification of mechanism of PSO; therefore we could not explain the exact action of PSO on AGA patients. However, the simplified International Index of Erectile Function (IIEF-5) was surveyed at baseline and 24 weeks because of identification of changes of libido and no significant intergroup differences were observed (data not shown, P = 0.774). The final limitation is degree of accuracy when assessing changes of hair by phototrichography, even though hair analysis was performed with confirmation of recorded target area in baseline. Nevertheless, our results have a value because current study was conducted based on the randomized controlled trials which evaluated hair changes using photographs as well as phototrichography.
Despite of these limitations, this double-blinded study did involve 76 subjects and, to the best of the authors' knowledge, is the first study to examine the long-term efficacy of PSO on AGA. The study shows that PSO could improve AGA and that it should be considered a potential alternative treatment. However, replication will be needed in order to confirm the results of this first-stage study and additional studies are required to elucidate the mechanism responsible for the positive effects of PSO on AGA.
This study was supported by a grant from Dreamplus Co., Ltd. (2012).
References
1. Olsen EA, Messenger AG, Shapiro J, et al. Evaluation and treatment of male and female pattern hair loss. Journal of the American Academy of Dermatology. 2005;52(2):301–311. [PubMed]
2. Hoffmann R. Male androgenetic alopecia. Clinical and Experimental Dermatology. 2002;27(5):373–382. [PubMed]
3. Lee W, Lee H. Characteristics of androgenetic alopecia in Asian. Annals of Dermatology. 2012;24:243–252. [PMC free article] [PubMed]
4. Semalty M, Semalty A, Joshi GP, Rawat MSM. Hair growth and rejuvenation: an overview. Journal of Dermatological Treatment. 2011;22(3):123–132. [PubMed]
5. Kaufman KD. Androgens and alopecia. Molecular and Cellular Endocrinology. 2002;198(1-2):89–95. [PubMed]
6. Kaufman KD, Olsen EA, Whiting D, et al. Finasteride in the treatment of men with androgenetic alopecia. Journal of the American Academy of Dermatology. 1998;39(4):578–589. [PubMed]
7. Libecco JF, Bergfeld WF. Finasteride in the treatment of alopecia. Expert Opinion on Pharmacotherapy. 2004;5(4):933–940. [PubMed]
8. Rapaport MJ. Follow-up of 1 mg finasteride treatment of male pattern baldness-difference between clinical trials and private office follow-up: influences on prescribing habits evaluated. Dermatologic Surgery. 2004;30(5):761–763. [PubMed]
9. Esfandiari A, Kelly AP. The effects of tea polyphenolic compounds on hair loss among rodents. Journal of the National Medical Association. 2005;97(8):1165–1169. [PMC free article] [PubMed]
10. Kwon OS, Han JH, Yoo HG, et al. Human hair growth enhancement in vitro by green tea epigallocatechin-3-gallate (EGCG) Phytomedicine. 2007;14(7-8):551–555. [PubMed]
11. Hong H, Kim C, Maeng S. Effects of pumpkin seed oil and saw palmetto oil in Korean men with symptomatic benign prostatic hyperplasia. Nutrition Research and Practice. 2009;3:323–327. [PMC free article] [PubMed]
12. Carbin B-E, Larsson B, Lindahl O. Treatment of benign prostatic hyperplasia with phytosterols. British Journal of Urology. 1990;66(6):639–641. [PubMed]
13. Norwood OT. Male pattern baldness: classification and incidence. Southern Medical Journal. 1975;68(11):1359–1365. [PubMed]
14. Canfield D. Photographic documentation of hair growth in androgenetic alopecia. Dermatologic Clinics. 1996;14(4):713–721. [PubMed]
15. Kawashima M, Hayashi N, Igarashi A, et al. Finasteride in the treatment of Japanese men with male pattern hair loss. European Journal of Dermatology. 2004;14(4):247–254. [PubMed]
16. Takahashi T, Kamiya T, Hasegawa A, Yokoo Y. Procyanidin oligomers selectively and intensively promote proliferation of mouse hair epithelial cells in vitro and activate hair follicle growth in vivo. Journal of Investigative Dermatology. 1999;112(3):310–316. [PubMed]
17. Al-Sereiti MR, Abu-Amer KM, Sen P. Pharmacology of rosemary (Rosmarinus officinalis Linn.) and its therapeutic potentials. Indian Journal of Experimental Biology. 1999;37(2):124–130. [PubMed]
18. Pandit S, Chauhan NS, Dixit VK. Effect of Cuscuta reflexa Roxb on androgen-induced alopecia. Journal of Cosmetic Dermatology. 2008;7(3):199–204. [PubMed]
19. Tsuruki T, Takahata K, Yoshikawa M. Anti-alopecia mechanisms of soymetide-4, an immunostimulating peptide derived from soy ß-conglycinin. Peptides. 2005;26(5):707–711. [PubMed]
20. Kim SH, Jeong KS, Ryu SY, Kim TH. Panax ginseng prevents apoptosis in hair follicles and accelerates recovery of hair medullary cells in irradiated mice. In Vivo. 1998;12(2):219–222. [PubMed]
21. Datta K, Singh AT, Mukherjee A, Bhat B, Ramesh B, Burman AC. Eclipta alba extract with potential for hair growth promoting activity. Journal of Ethnopharmacology. 2009;124(3):450–456. [PubMed]
22. Yoon JI, Al-Reza SM, Kang SC. Hair growth promoting effect of Zizyphus jujuba essential oil. Food and Chemical Toxicology. 2010;48(5):1350–1354. [PubMed]
23. Sawaya ME. Novel agents for the treatment of alopecia. Seminars in Cutaneous Medicine and Surgery. 1998;17(4):276–283. [PubMed]
24. Rossi A, Mari E, Scarno M, et al. Comparitive effectiveness of finasteride versus Serenoa repens in male androgenetic alopecia: a two-year study. International Journal of Immunopathology and Pharmacology. 2011;25:1167–1173. [PubMed]
25. Zambo I. Analytical standardization of peponen. Mediflora. 1988;89:p. 6.
26. Gossell-Williams M, Davis A, O’Connor N. Inhibition of testosterone-induced hyperplasia of the prostate of Sprague-Dawley rats by pumpkin seed oil. Journal of Medicinal Food. 2006;9(2):284–286. [PubMed]
PUMPKINSEED OIL PATENTS
Personal care compositions comprising squash or pumpkin extract
AU2012302146
Embodiments of the present invention relate to novel personal care compositions for cleaning and moisturizing the skin or hair comprising an extract of squash and/or pumpkin, a preservative and a cosmetic base. Other embodiments of the present invention relate to methods of making and methods of using the personal care compositions.
[0001] The present invention relates to novel personal care compositions for cleaning and moisturizing the skin or hair comprising an extract of squash and/or pumpkin and methods of making and using then BACKGROUND [0002] Personal care compositions such as shampoos, conditioners, body washes, face creams, and lotions, and methods of using them, are a normal part of daily life. Such personal care corupositions are useful for nourishment and maintenance of the health of the skin and hair and improve the physical appearance of consumers. However, many personal care compositions are made from chemicals that consumers are unfamiliar with and that are derived from non natural sources. There is rising interest in products that are made from natural sources that are effective, environmentally friendly and falihar to consumers. What is needed, therefore, are personal care composite ions made from ingredients that are derived from natural sources, and methods of making and using them.
Methods of Making the Personal Care Compositions Preparation of Squash and/or Pumpkin Extract
[0012] All the squash and/or pumpkin extracts described herein were made at room temperature.
Sterilized containers and utensils were used, and the preparer cleaned and sterilized hands and wore sterile food preparation plastic gloves. The squash and/or pumpkin extracts were generally made with the following method: a) obtaining squash and/or pumpkin; b) removing the stem from the squash and/or pumpkin; c) dicing the squash and/or pumpkin to obtain fragments;
d) juicing the squash and/or pumpkin fragments to obtain a liquid; e) straining the liquid to obtain the squash and/or pumpkin extract; f) adding preservative to the squash and/or pumpkin extract.
At this stage, the squash and/or pumpkin extract with added preservative may be stored in sterile containers. The squash and/or pumpkin extract with added preservative is preferably stored in a refrigerator.
[0013] In yet another embodiment the present invention provides methods of making an extract of squash. Such methods include: obtaining squash; removing the stem, dicing squash to obtain fragments; juicing the squash fragments to obtain a liquid; and straining the liquid to obtain the squash extract. The preservative is then added to the extract.
[0014] In yet another embodiment the present invention provide methods of making an extract of pumpkin. Such methods include: obtaining pumpkin; removing the stem, slicing pumpkin to obtain fragments; juicing the pumpkin fragments to obtain a liquid; and straining the liquid to obtain the pumpkin extract. The preservative is then added to the extract.
[0015] In another embodiment, the pumpkin extract and the butternut squash extract may be prepared separately and then combined in a desired proportion to make a combined pumpkin and squash extract. The preservative may be added to the extract combined extracts or to each extract before combining the extracts.
[0016] In one embodiment the present invention provides methods of making an extract of butternut squash and pumpkin. Such methods include: obtaining butternut squash and/or pumpkin; removing the stem, slicing the butternut squash and pumpkin to obtain fragments;
juicing the butternut squash and pumpkin fragments to obtain a liquid; and straining the liquid to obtain the butternut squash and pumpkin extract.
In another embodiment, the pumpkin extract and the butternut extract may be prepared separately and then combined in a desired proportion to make a combined pumpkin and butternut squash extract. The preservative may be added to the extract combined extracts or to each extract before combining the extracts.
[0017] In another specific embodiment the present invention provide methods of making an extract of butternut squash. Such methods include: obtaining butternut squash; removing the stem, slicing the butternut squash to obtain fragments; juicing the butternut squash fragments to obtain a liquid; and straining the liquid to obtain the butternut squash extract. The preservative is then added to the extract.
[0018] Other embodiments of the present invention provide methods of making personal care compositions comprising a base and an extract of squash and/or pumpkin. All the personal care compositions described herein were made at room temperature. Sterilized containers and utensils were used, and the preparer cleaned and sterilized hands and wore sterile food preparation plastic gloves. Such methods include: a) obtaining squash and/or pumpkin; b) removing the stem from the squash and/or pumpkin; c) dicing the squash and/or pumpkin to obtain fragments; d) juicing the squash and/or pumpkin fragments to obtain a liquid; e) straining the liquid to obtain the squash and/or pumpkin extract; f) adding preservative to the squash and/or pumpkin extract and g) mixing the squash and/or pumpkin extract with an amount of base at room temperature until combined. In some embodiments, the methods comprise the addition of other ingredients, such WO 2013/033087 PCT/US2012/052650 as, emulsifiers, surfactants, and fragrances. The additional ingredients may also be naturally derived ingredients.
Ingredients and Percentage Ranges of Specific Embodiments of Pumpkin and/or Squash Extract
[0019] The compositions of the invention comprise an extract made of squash/and or pumpkin. In one embodiment, the extract may be made from 100% squash. In another embodiment, the extract may be made from 100% pumpkin. In other embodiments, the extract may be made from a combination of squash and pumpkin. All numbers in this paragraph are in volume percent (vol %). In one embodiment, the extract is made from a combination of 50% squash and 50% pumpkin. In another embodiment, the extract is made from a combination of 75% squash and 25% pumpkin. In another embodiment, the extract is made from a combination of 70% squash and 30% pumpkin. In another embodiment, the extract is made from a combination of 60% squash and 40% pumpkin. All of these different ratios (50:50, 75:25, 70:30, and 60:40, squash:pumpkin) have been made and work. When the extract is made from a combination of squash and pumpkin, any amount of pumpkin between 0% and 100% and any amount of squash between 100% and 0% may be used. In other embodiments, the combined extract is made from about 1%, 5%, 10%, 15%, 2 0%, 2 5%, 3 0%, 35%, 4 0%, 45%, 50%, 55%, 6 0% , 6 5%, 70%, 75%, 8 0%, 8 5%, 9 0%, 95%, or 99% squash, and from about 1%, 5%, 10%, 15%, 2 0%, 2 5%, 3 0%, 35%, 4 0%, 45%, 50%, 55%, 6 0%, 6 5%, 70%, 75%, 80%, 8 5%, 90 %, 95%, or 99% pumpkin for a total of 100%. It is to be understood that any ratio of pumpkin to squash may be used to prepare the extract. Once the extract has been prepared, other ingredients may be added to the extract, such as a preservative. In one embodiment, the preservative benzyl alcohol DHA is added to the extract. In another embodiment, phenonip and germall are added as preservatives, alone or in combination, to the extract. In one embodiment, the preservative potassium benzoate is added to the extract. In yet another embodiment, phenonip, germall and potassium benzoate are added as preservatives to the extract.
[0020] In a specific embodiment, the squash is butternut squash and the compositions of the invention comprise an extract made of butternut squash/and or pumpkin. In one embodiment, the extract may be made from 100% butternut squash. In another embodiment, the extract may be made from 100% pumpkin. In other embodiments, the extract may be made from a combination of butternut squash and pumpkin. In one embodiment, the extract is made from a combination of 50% butternut squash and 50% pumpkin. In another embodiment, the extract is made from a combination of 75% butternut squash and 25% pumpkin. In another embodiment, the extract is 6 WO 2013/033087 PCT/US2012/052650 made from a combination of 70% butternut squash and 30% pumpkin. In another embodiment, the extract is made from a combination of 60% butternut squash and 40% pumpkin. All of these different ratios (50:50, 75:25, 70:30, and 60:40, butternut squash:pumpkin) have been made and work. When the extract is made from a combination of butternut squash and/or pumpkin, any amount of pumpkin between 0% and 100% and any amount of butternut squash between 100% and 0% may be used. In other embodiments, the combined extract is made from about 1%, 5%, 10%, 15%, 2 0%, 2 5%, 3 0%, 35%, 4 0%, 45%, 50%, 55%, 60%, 6 5%, 70%, 75%, 80%, 8 5%, 9 0% , 9 5%, or 99% butternut squash, and from about 1%, 5%, 10%, 15%, 2 0%, 2 5%, 3 0%, 35%, 4 0% , 45%, 50%, 55%, 60%, 6 5%, 70%, 75%, 8 0%, 85%, 9 0%, 95%, or 99% pumpkin for a total of 100%. It is to be understood that any ratio of butternut pumpkin to squash may be used to prepare the extract. Once the extract has been prepared, other ingredients may be added to the extract, such as a preservative. In one embodiment, the preservative benzyl alcohol DHA is added to the extract. In another embodiment, phenonip and germall are added as preservatives, alone or in combination, to the extract. In one embodiment, the preservative potassium benzoate is added to the extract. In yet another embodiment, phenonip, germall and potassium benzoate are added as preservatives to the extract.
[0021] In preparing the extract of squash, the extract of pumpkin, or the combined extract of squash and pumpkin, stalks were removed from the squash and from the pumpkin which were then diced into small pieces, and run through a juicer to obtain the liquid extract of squash, pumpkin or squash and pumpkin. The liquid extract of squash, pumpkin, or squash and pumpkin, was then put through a strainer to remove any traces of the pulp, preservative was added to the strained liquid extract which was then placed in a sterile container.
Shampoo
[0022] One specific embodiment of the present invention is a shampoo made in accordance with the formula shown in Table 1. The shampoo may also be made with the listed ingredients in the quantities covered by the percentage range.
Table 1. Shampoo Formula Percentage and Ingredient Range (vol%) 15% (5-2 5%) Pumpkin and/or Butternut Squash extract (including a preservative such as benzyl alcohol DHA, potassium benzoate, or phenonip and germall, or a combination thereof such as potassium benzoate, phenonip and germall) 10% (0-20%) Pumpkin Blossom Honey & Mountain Honey Blend 2 .5% (0-10%) lOx Concentrated Aloe Vera Extract 7 WO 2013/033087 PCT/US2012/052650 1.5% (0-10%) Eucalyptus Oil 1% (0-10%) Lavender Oil 5% (0-15%) Sea Salt 65% (55-75%) Shampoo Base (Water, decyl glucoside, cocamide betaine, lauramide diethanolamine (DEA), lauryl glucoside, disodium ethylenediaminetetraacetic acid (EDTA), methylchlorisothiazolinone, methylisothiazolinone, citric acid, sodium chloride, vitamin A, vitamin D, vitamin E, hemp oil, avocado oil, coconut oil) [0023] In this embodiment, the unscented shampoo base was obtained from Bulk Apothecary (Ohio, USA, commercially available online at www.bulkapothecary.com).
Hair Conditioner [0024] Another specific embodiment of the present invention is a conditioner made in accordance with the formula shown in Table 2. The conditioner may also be made with the listed ingredients in the quantities covered by the percentage range.
Table 2. Hair Conditioner Formula Percentage and Ingredient Range (vol%) 15% (5-2 5%) Pumpkin and/or Butternut Squash extract (including a preservative such as benzyl alcohol DHA, potassium benzoate, or phenonip and germall, or a combination thereof such as potassium benzoate, phenonip and germall) 10% (5-25%) Pumpkin Blossom Honey 5% (0-15%) 1Ox Aloe Vera Extract 5% (0-15%) Cyclo-dimethicone 3.5% (0-10%) Eucalyptus Oil 1.5% (0-10%) Lavender Oil 5% (0-15%) Cocamide betaine Conditioner base (Water, glycerin, emulsifying wax, mineral oil, quanternium-7, polyvinylpyrrolidone (pvp), glyceryl stearate, 55% (45-65%) stearalkonium chloride, ethoxydiglycol, propylene glycol, butylene glycol, extracts of matricaria, nettle, birch sap, arnica, cinchona, and birch leaf, potassium sorbate, sodium benzoate, imidazolidinyl urea ) [0025] In this specific embodiment, the conditioner base (conditioner base ultra premium was obtained from New Directions Aromatics (New Directions Aromatics Inc., 2129 Watercress P1., San Ramon, CA 94583, USA, also commercially available online at newdirectionsaromatics.ca)).
Face Cream [0026] Another specific embodiment is a face cream made in accordance with the formula shown in Table 3. The face cream may also be made with the listed ingredients in the quantities covered by the percentage range.
Table 3. Face Cream Formula Percentage and Ingredient Range (vol%) 30% (20-40%) Pumpkin and/or Butternut Squash extract (including a preservative such as benzyl alcohol DHA, potassium benzoate, or phenonip and germall, or a combination thereof such as potassium benzoate, phenonip and germall) 10% (0-20%) Pumpkin Blossom Honey & Mountain Honey Blend 10% (0- 2 0%) lOx Concentrated Aloe Vera Extract 10% (0-20%) Cranberry Seed Oil 4%(0-13%) Gel Maker Emulsifier 4% (0-12%) Eucalyptus oil 2% (0-12%) Lavender oil 30% (20-40%) Face Cream Base (Water, Cetearyl Alcohol, Ceteareth-20 Glycerin, Shea butter (Butyrospermum Parkii), Palm Oil Coconut (Cocos Nucifera), Oil Glyceryl Monostearate, Sunflower (Helianthus Annus) Seed Oil Beeswax (Cera Alba), Dimethicone, Phenoxyethanol, Carbomer, Tocopherol (Vitamin E), Sodium Citrate [0027] In this embodiment, the face cream base (Cream Base ultra premium) and cranberry seed oil were purchased from New Directions Aromatics (New Directions Aromatics Inc., 2129 Watercress P1., San Ramon, CA 94583, USA, also commercially available online at newdirectionsaromatics.ca). Any commercially available honey may be used.
EXAMPLE 1 Shampoo Formula
A shampoo was made in accordance with the formula shown in Table 6.
Table 6. Shampoo Formula Quantity (by vol.) Volume % Ingredient (fluid ounces) (ml) of total 2.25 oz. (66.5ml) 17 Butternut Squash:Pumpkin extract (with benzyl alcohol DHA) 1.5 oz. (44.4 ml) 11 Pumpkin Blossom Honey & Mountain Honey Blend 0.5 oz. (14.8 ml) 3.5 1Ox Concentrated Aloe Vera Extract 0.125 oz. (3.7 ml) 0.9 Eucalyptus Oil 0.062 oz. (1.93 ml) 0.4 Lavender Oil 0.5 oz. (14.8 ml) 3.6 Sea Salt 9 oz. (266.2 ml) 64 Shampoo Base (Water, decyl glucoside, cocamide betaine, lauramide diethanolamine (DEA), lauryl glucoside, disodium ethylenediaminetetraacetic acid (EDTA), methylchlorisothiazolinone, methylisothiazolinone, citric acid, sodium chloride, vitamin A, vitamin D, vitamin E, hemp oil, avocado oil, coconut oil) Total 100 13.9 oz. (411 ml) Method of making the shampoo
[0037] The shampoo was made in accordance with the following method.
1. 11.2 fluid ounces (331.1 ml) of butternut squash and 4.8 fluid ounces (141.9 ml) of pumpkin were obtained to make the butternut squash and pumpkin extract as described above.
2. Approximately 2 fluid ounces (59 ml) of benzyl alcohol DHA was added to every quart (946.4 ml) of strained butternut squash and pumpkin extract.
3. In a separate sterile container, the honey, aloe vera extract, lavender oil, eucalyptus oil, and sea salt were added sequentially and thoroughly mixed. The butternut squash and pumpkin extract was then added and mixed thoroughly using a mechanical mixer with a whisk attachment.
The shampoo base was added to the mixture and mixed using the mechanical mixer until it was smooth. The shampoo was then distributed into 8 individual bottles, each containing about 355 ml (12 fluid ounces).
Results of using shampoo [0038] Three individuals tested the shampoo by using it instead of their normal shampoo.
After four weeks of regularly using the shampoo to clean her hair, one individual reported that the texture of her hair was softer and that her hair was easier to manage. Another person noted that her hair was shinier and stated that she enjoyed the scent of her hair. A third individual stated 12 WO 2013/033087 PCT/US2012/052650 that her hair had more body and volume after using the shampoo, and also noted that her hair was shinier.
EXAMPLE 2 Hair Conditioner Formula [0039] A conditioner was made in accordance with the formula shown in Table 7.
Table 7. Conditioner Formula Quantity (by vol.) Volume Ingredient (fluid ounces) (ml) % of total 2.25 oz. (66.5ml) 14.8 Butternut Squash:Pumpkin extract (with benzyl alcohol DHA) 1.5 oz. (44.4 ml) 9.9 Pumpkin Blossom Honey 0.75 oz. (22.2 ml) 4.9 1Ox Aloe Vera Extract 1 oz. (29.6 ml) 6.6 Cyclo-dimethicone 0.125 oz. (3.7 ml) 0.8 Eucalyptus Oil 0.062 oz. (1.84 ml) 0.4 Lavender Oil 1 oz. (29.6 ml) 6.6 Cocamide betaine 56 Conditioner base (Water, glycerin, emulsifying wax, mineral oil, quanternium-7, polyvinylpyrrolidone, glyceryl stearate, 8.5 oz. (251.4ml) stearalkonium chloride, ethoxydiglycol, propylene glycol, butylene glycol, extracts of matricaria, nettle, birch sap, arnica, cinchona, and birch leaf, potassium sorbate, sodium benzoate, imidazolidinyl urea) Total 100 15.18 oz (448.9 ml) Method of'making the conditioner [0040] The conditioner was made in accordance with the following method.
1. 11.2 fluid ounces (331.1 ml) of butternut squash and 4.8 fluid ounces (141.9 ml) of pumpkin were obtained to make the butternut squash and pumpkin extract as described above.
2. Approximately 2 fluid ounces (59 ml) of benzyl alcohol DHA was added to every quart (946.4 ml) of strained butternut squash and pumpkin extract.
3. In a separate sterile container, the honey, aloe vera extract, lavender oil, eucalyptus oil, cyclo-dimethicone, and cocamide betaine were added sequentially and thoroughly mixed. The butternut squash and pumpkin extract was then added and mixed thoroughly using a mechanical mixer with a whisk attachment.
4. The conditioner base was added to the mixture and mixed with the mechanical mixer until it was smooth.
[0041] The conditioner was then distributed into individual bottles.
Results of using the conditioner [0042] The conditioner was tested by two individuals that used the conditioner instead of their normal hair conditioner. One person noted that the conditioner smoothed and tamed her hair and made it easier to comb. She also stated that the conditioner moisturized and hydrated her hair.
Another person also stated that the conditioner made her hair smoother and more manageable. She also stated that using the conditioner prevented her hair from tangling.
&c...
Results of Using the Body Lotion
[0072] Five individuals provided the following reports. "This leaves my skin feeling smooth and soft and also smells amazing!" "Makes my skin feel smooth and also smells great but not overbearing." "I have been using this product for about 6 months and I can really see a difference in the way my skin feels. I also noticed that when I get razor burn on my legs, the lotion soothes the irritation and makes the red bumps go away." "I use it every day, and I love the way it makes 24 WO 2013/033087 PCT/US2012/052650 my skin feel soft and smooth." "I love it! The scent is great and it leaves a silky shiny look on my skin."
EXAMPLE 13 Face Cream Formula [0073] A face cream was made in accordance with the formula shown in Table 18.
Table 18 Quantity (by vol.) Volume % of total Ingredient 4 cups (946 ml) 39 Face Cream base 4 cups (946 ml) 39 Butternut Squash:Pumpkin extract (70%:30%) containing 1% liquid germall plus (vol%), 1% phenonip (vol%) & 1% potassium benzoate 2 Tablespoons (29.6 ml) 1.2 potassium ascorbate 1 cup (118 ml) 4.9 Honey 12 cup (118 ml) 4.9 Aloe Vera 12 cup (118 ml) 4.9 Cranberry Seed Oil 1/3 cup (78.1 ml) 3.2 Gel Maker -EMU 2 teaspoons (9.9 ml) 0.4 Citric Acid 2 tablespoons (29.6 ml) 1.23 Tripeptide 5 2 teaspoons (9.9 ml) 0.4 Fragrance -cucumber melon Total 2405 ml 100% [0074] The butternut squash/pumpkin extract containing 1% germall, 1% phenonip and 1% potassium benzoate was added to the face cream base and mixed well with a mechanical mixer.
Next potassium ascorbate was added and mixed well. The honey, Aloe Vera extract, and cranberry seed oil were then sequentially added and mixed. Next the gel maker-EMU, citric acid, tripeptide 5 and fragrance were sequentially added and mixed well. This produced 19 - 4 oz. (118.3 ml) jars.
Results of Using the Face Cream [0075] Four individuals provided the following reports. "I love putting this on at night and waking up the next morning with soft skin. It doesn't clog my pores either." "No more searching for the right face cream. Not too dry but not too oily, just perfect for every skin type!" "I have semi-oily skin and this cream has worked wonders for me. It leaves my skin feeling soft and smooth." "Makes my skin feel soft and the scent is not too powerful, it's just right."
EXAMPLE 14 Shampoo Formula
[0076] A shampoo was made in accordance with the formula shown in Table 19.
Table 19 Quantity (by vol.) Volume % Ingredient of total 8 cups (1.892 L) 55.5 Shampoo base 4 cups (946.4 ml) 27.7 Butternut Squash:Pumpkin extract (70%:30%) containing 1% liquid germall plus (vol%), 1% phenonip (vol%) & 1% potassium benzoate 2 tablespoons (29.6 ml) 0.9 potassium ascorbate 1 cup (236 ml) 6.9 cocamide betaine 12 cup (118 ml) 3.5 Aloe Vera extract 1 cup (118 ml) 3.5 Honey 14 cup (59.1 ml) 1.7 Glucose-T 2 teaspoons (9.9 ml) 0.3 Fragrance pink lemonade Total 3410 ml 100% [0077] The strained butternut squash/pumpkin extract containing 1% germall, 1% phenonip and 1% potassium benzoate was added to the shampoo base and mixed well with a mechanical mixer. Next potassium ascorbate was added and mixed well. The cocamide betaine, Aloe Vera extract, Honey, Glucose-T, and fragrance were then sequentially added and mixed. This produced 8 -12 oz. (355 ml) bottles.
Results of Using the Shampoo [0078] Five individuals provided the following individual reports. "This product lathers better than any shampoo I've ever used, and the way it makes my hair feel is phenomenal!" "After using only name brand products for years, I have found that this shampoo has made a tremendous difference in the texture and appearance of my hair." "I love the shampoo and the way it makes my hair feel. I also have a dry scalp and it doesn't make it worse." "I really love the way it makes my hair feel soft and looks fuller with more body." "I have tried very expensive brands of shampoo, and when I started using Early Harvest I noticed it makes my hair just as, if not more, bouncy and smooth to the touch." 26 WO 2013/033087 PCT/US2012/052650 EXAMPLE 15 Conditioner Formula [0079] A conditioner was made in accordance with the formula shown in Table 20.
Table 20 Quantity (by vol.) Volume % Ingredient of total 8 cups (1.892 L) 61 Conditioner base 2 cups (473 ml) 15 Butternut Squash:Pumpkin extract (70%:30%) containing 1% liquid germall plus (vol%), 1% phenonip (vol%) & 1% potassium benzoate 1 tablespoon (14.8 ml) 0.5 potassium ascorbate 2 cups(473 ml) 15 Cyclo-dimethicone 12 cup (118.3 ml) 3.8 Aloe Vera extract 1 cup (118.3 ml) 3.8 grape seed oil 1/8 cup (29.6 ml) 0.9 Apple Cider Vinegar 2 teaspoons (9.9 ml) 0.3 Fragrance - pink lemonade Total 3128 ml 100% [0080] The strained butternut squash/pumpkin extract containing 1% germall, 1% phenonip and 1% potassium benzoate was added to the conditioner base and mixed well with a mechanical mixer. Next potassium ascorbate was added and mixed well. The Cyclo-dimethicone, Aloe Vera extract, grape seed oil, apple Cider Vinegar and fragrance were then sequentially added and mixed well. This produced 8 -12 oz. (355 ml) bottles.
Results of Using the Conditioner [0081] Five individuals provided the following reports. "It didn't make my hair feel heavy or oily like a lot of other conditioners I've used in the past." "The shampoo and conditioner combined have left my hair feeling softer and easier to manage." "This product moisturizes my hair and scalp, leaving it soft and smooth. I also noticed that when I put color on my hair, it often leaves it dry and brittle, but when I use this conditioner it smoothes the follicle down making it easier to brush and style." "The conditioner doesn't make my hair too soft or too flat, like a lot of conditioners can do. It also makes my hair more manageable." "I like it a lot, because it doesn't weigh my hair down or over condition it leaving it oily....
NATURAL COMPOSITION FOR PREVENTING LOSS OF HAIR AND RECOVERING OF SILVERHAIR
KR20130075207
HAIR RESTORER COMPOSITION CONTAINING CARROT, RADISH, PUMPKIN, CUCUMBER AND BEAN SPROUT
KR20110110650
PERORAL HAIR-GROWTH STIMULANT
JP2011105695
THE MANUFACTURING METHOD OF SHAMPOO COMPOSITION PREVENTING LOSS OF HAIR, AND THE PRODUCT
KR20090097316
THERAPEUTIC AGENT
JP2009184940
COMPOSITION AND USES THEREOF
US2009175808
Skin and hair aerosol foam preparations containing an alkyl polyglycoside and vegetable oil
US6045779
Composition for the prevention and treatment of the detrimental effects of dihydrotestosterone
US2006009430
AGENT FOR HAIR CARE
RU95104758
METHOD FOR MANUFACTURING NATURAL AGENT FOR HAIR GROWTH
KR20040001683
COSMETIC FOR SKIN OR HAIR
JP2008088105
HAIR COSMETIC COMPOSITION, AND METHOD FOR PRODUCING THE SAME
JP2005015415
Process for the manufacture of a hair lotion
CH611157
HAIR POMADE COMPOSITION AND METHOD OF MAKING THE SAME
US7479292
PROPHYLACTIC MEANS
BG106355
Vision Regeneration by Magnets
DE19808979
Regenerator for vision of human eye
Inventor(s): REIN HANS HELMUT
Abstract -- The regenerator is in the form of a helmet placed over the head and containing cylindrical permanent magnets positioned on the front of the head directly in front of the eyes, and on the back of the head directly in front of the cortex. The permanent magnets have two or more poles, and are magnetically screened on the side facing away from the body. The magnets are contained in adjustable holders adaptable to the size and shape of the head. The helmet consists of a ring and one or more straps.
Description
The invention relates to a device for regenerating the vision of the eye, characterized in that it comprises a helmet-like shape to be placed on the head, and that in this form permanent magnets are mounted, their positions on the head and front right under the nose and on the head back are right in front of the visual cortex.
The state of the medical school and the medical research takes as a given that the vision of the human eye changes over the course of a life and that this change is a unbeeinflussbarer and irreversible process.
Accordingly, the well-known medical technology focused on correcting the instantaneous optical conditions in the eyes of people.
This is done in a known manner by the use of corrective lenses, either in the form of glasses or a contact lens.
A newer type of correction is the removal of layers or otherwise correcting the cornea with fine mechanical means or laser tools to produce by a change in shape of the corneal surface optimal optical conditions.
Such surgical refractive power corrections to the cornea have been described in protection applications, for example in U.S. Patent No. 47 29 372, U.S. Patent 47 18 418, WO 87/05 496 and EP 01 51 869
With all these surgical procedures, the known risks of scarring, cataract, side effects of anesthetics and irregular course of the healing process are connected.
Do not remove the causes of Sehfähigkeits-change, but correct their consequences.
Published patent application DE 41 31 361 A1 describes a method for changing the vision of the eye in which the cornea no surgical intervention, but UV radiation is exposed to an excimer laser, which continue to exert radiation pattern, imaging optics and fixing a transformative effect on the cornea.
This one arisen mismatch between corneal curvature and distance to the retina is corrected, but does not eliminate the cause of the emergence of this mismatch.
Utility Model Application G 90 11 254.7 describes a Therapeutic glasses, whose job it is to heal through constant magnetic stimulation of neural areas near the eyes a number of eye diseases.
This also nearsightedness and farsightedness are enumerated among many diseases that are treated by a magnetic excitation of the points A or C.
All points mentioned there are outside of the eye sockets on the nasal bone (A) and directly below the eyes (C) The other stimulation points are point D in mid-brow and point B at the outer end of the eye socket.
A targeted regeneration of eye-vitreous body is therefore not intended and can not be reached.
Therefore, the application speaks regarding Far-sightedness and not of healing but of treatment.
Task
The present invention has for its object to provide a device by means of the application of the visual acuity of the eyes is regenerated without surgical intervention and without the necessity of wearing a pair of spectacles or contact lenses.
Under regeneration of vision is understood here that the generally taken-for uninfluenceable deterioration of vision of the eye, which in advancing age is getting stronger, be reversed and the previously existing vision is restored.
As a deeper cause for the so-called age-related Sehfähigkeits deterioration by environmental causes disability of the body's mechanisms have been identified for regeneration and maintenance conservation of light diffraction ability of the eye-glass body.
The object of the inventive device, therefore, is to enable the body's regeneration mechanisms in the position of this light diffraction ability of the eye vitreous restore and maintain.
The treatment of the eye to regenerate the vision to be carried out without the need for an inpatient hospital stay and without risks and side effects.
You should continue with no changes to the device and without changes to the application s mode, and without additional cost to the patient or user at any time be repeatable even after several years, for example if a more prolonged high environmental burden to the patient or user this requires.
Solution of the problem
To achieve the object, the invention proposes a device for regenerating the vision of the eyes before which consists of a helmet-like shape to be placed on the head, are attached in which permanent magnets whose positions on the head-front directly in front of the eyes and on the head back are right in front of the visual cortex.
The invention is based on the finding that the cornea and the lens are not the only places in the eye, which concentrate the incident light by refraction such that the focal point of its rays is on the retinal surface.
Rather, the eye-glass body, achieved through its gel-like mass, the light rays of the retina, an additional correction function, which is that light rays undergo diffraction in different thickness and therefore reach the retinal surface differentiated than has hitherto been assumed.
It was further recognized that these light diffraction needs within the eye-glass body of an inhomogeneous structure of the vitreous body and a complex neural control, which in turn is very sensitive to external influences.
Obviously particularly stable charging and poling conditions when the gel particles in the glass body and the cells around the glass bodies are decisive for the continued maintenance of said glass body function.
This charge and Polungsverhältnisse are mainly disturbed by the myriad of alternating electromagnetic fields emanating from domestic electrical installations, radio and television.
It has been shown in long series of experiments, surprisingly, that it is possible by the selective action of a particular steady magnetic field directly on the eye-glass body and the visual cortex located at the back of the head, to enable the body's own regeneration mechanism in the situation, the negative effects of these electromagnetic alternating fields to eliminate and thus the original and natural vision conditions of the eye, to restore it.
This regeneration process the longer it takes, the more the poling and charge ratios were disrupted in and around the eye-glass body and could not regenerate.
As any rule of thumb it can be assumed that the body needs the targeted permanent magnet treatment for a period of 6-12 months to compensate for the negative effects of alternating field stress of 20 years.
The treatment must take during this period about 5 times each 4 minutes per day.
The simultaneous treatment of vitreous body and visual cortex has been found to be time-shortening, ie, a treatment of the vitreous alone would take twice as long.
To solve the problem, therefore, the invention proposes a device for regenerating the vision of the eyes, which consists of a helmet-like shape to be placed on the head, are attached in which permanent magnets whose positions on the head-front directly in front of the eyes and on the head back are right in front of the visual cortex.
The helmet-like shape can be made as a closed or open form, or consisting of a solid, containing the mountings for the permanent magnets, anatomically advantageous shaped ring and one or more, above the head extending and adjustable straps.
The permanent magnets are advantageously mounted in holders, which in adaptation to different head sizes and head shapes their exact positioning in front of the eyes, respectively, before the visual cortex allow.
Furthermore, the holders of the permanent magnets are advantageously designed so that the permanent magnets can be approximated on the head-front to eye contact and closer to the head back up to head contact.
The strength of the permanent magnets used in the present invention is defined with a remanence Br between 135 mT and 295 mT and an energy product (BH) max. between 3 and 16 kJ/m.sup.3 kJ/m.sup.3.
The device is equipped with a timer, the expiry of which the necessary treatment time of about 4 minutes signaled acoustically.
Another embodiment provides an automatic way abandonment of the permanent magnets of the eyes after the treatment period.
Other claims relate to the shape and size as well as the polarity of the permanent magnets, as well as adjustment facilities and a safety strap serving on the helmet-like shape.
ADVANTAGES OF THE INVENTION
The advantages achieved by the invention are compared with all surgical procedures in the elimination of health risks associated with these and the lower cost.
To non-surgically erwirkten correcting deformations of the cornea, the invention offers the advantage of lower costs as well as the advantage of the restoration of the original, natural visual conditions by regeneration of the glass body function of the eye, without making any artificial adjustments to the actually non-correction-requiring cornea.
Compared with therapeutically acceptable glasses are the advantages in elimination of wearing such glasses, as the inevitably heavy glasses in professional and private life often seem distracting, and in the safer effect due to the eradication of the root causes of the deterioration of eyesight.
Compared to other therapeutic applications of permanent magnetic fields and other known treatment methods of the eyes are the advantages of targeted agents on the regeneration of light diffraction ability of the eye-glass body treatment without any side effect, harmful misapplication or over-dosage danger.
Drawings with descriptions
Figure
1: 3-section through a human eye with vitreous 1, 2 lens, cornea
2: Cross section through a human eye with vitreous 1, lens 2, 4 permanent magnet, magnetic shielding of the outer-facing side 5, therapeutically effective magnetic field 7, 6 mount for permanent magnet
3: helmet-like shape in closed version 8 with holders for permanent magnets on the head-front 6 in the eyes.
4: helmet-like shape in closed version 8 with holders for permanent magnets on the head back 9 before the visual cortex.
5: helmet-like shape open version 10 with holders for permanent magnets on the head-front 6 in the eyes.
Nano-Silver Health Dangers
http://www.naturalhealth365.com/food_news/silver-nanoparticles-1051.html
Jun. 25, 2014
Invisible toxins in food can damage
your health
by Jonathan Landsman
by Jonathan Landsman
You can’t see, smell or taste them – but over the last few years silver nanoparticles have been added to our food supply (and medications) at an alarming rate. Like me, I’m sure you’re wondering why would food producers – and the pharmaceutical industry – place silver in their products?
Consuming silver nanoparticles is a bad idea. These particles are sprayed onto produce – as a pesticide – and incorporated into food packaging to extend shelf life, due to their antimicrobial properties. But, scientific research warns us that the uptake of these tiny particles can cause cellular damage, kidney disorders, stomach upset, headaches, fatigue and skin irritation.
Nanoparticles causes premature aging
Researchers have demonstrated the devastating effects of silver nanoparticles on cell survival, and the integrity of the mitochondria.
Animals treated with silver nanoparticles exhibited reduced cognitive/motor functions and altered cellular structures in the brain. And, just to be clear, many scientific studies suggest that chronic exposure to silver nanoparticles can damage brain function. With all the pollution in our environment – should we really allow this technology to invade our food supply?
More research reveals an alarming toxic trend
Further data shows silver nanoparticles induce toxicity in neurons with the resulting dysfunction of physiological function. These particles, once digested, get distributed inside the brain, heart, and blood – which can result in cardiac arrhythmia, slower blood flow and impaired motor skills.
Observations, in laboratory animals, have shown that the uptake of these particles – in the digestive track – can change the terrain. The digestive track harbors beneficial bacteria along with pathogenic bacteria. Silver nanoparticles can wipe out the ‘good bacteria’ along with toxic ones.
Naturally, if you disturb the healthy balance of bacteria, within our gut, you comprise the immune system – setting the stage for degenerative disease.
Scientists detect nanoparticles on fruit
Scientists developed a new method for detecting silver nanoparticles in food during a study published in the Journal of Agricultural and Food Chemistry. This method was able to identify and measure relatively small amounts of these nanoparticles, in pears, according to Mengshi Lin, Ph.D. – study author and associate professor of food science at the University of Missouri.
The pears were immersed in a silver nanoparticle solution, similar to a pesticide application, and then washed and rinsed repeatedly. Four days after the treatment and rinsing, the silver nanoparticles were still attached to the skin and some even penetrated the skin to reach the pear pulp.
Many food packing materials incorporate silver nanoparticles to prolong the shelf life of packaged foods. The nano material has been known to transfer to the food – inside the package. I guess, after reading this, you’ll feel even better about eating fresh (unprocessed) food – as much as possible.
Nanoparticles can become airborne easily due to their size and mass. When inhaled, nanoparticles can go deeper into the lungs reaching more sensitive areas. These particles can inflame the lungs – which must work harder in attempts to remove the foreign particles.
The only known protection from nanoparticle toxins
It takes an incredibly small amount of this substance to cause health problems. In fact, the Food and Drug Administration (FDA) is on record saying that nanoparticles pose safety issues – because they significantly alter bioavailability properties of food, which alter how much your body can absorb a substance. This means it affects the amount of nutrients you absorb and the amount of toxins that can enter a cell.
Unfortunately, companies aren’t required to label or test nano materials in the food they sell you or the packing they put it in. To counter the ever increasing amount of nanoparticles in food – you have to look for whole foods, which aren’t commercially packaged. Apples, carrots, dark leafy greens and so on are healthy choices.
Buy local (whenever possible) – since foods that are transported long distances are often treated with nanosilver particles to keep them looking ‘fresh’. Organic produce is less likely to be treated with nanoparticles. Plus, we know that organic farming techniques avoid the use of sewage sludge fertilizer – which can be tainted with nanoparticles.
Thankfully, the world is changing and people are waking up to the truth about toxic food, medicine and personal care products. Vote with your dollars and be part of the solution.
References:
http://www.care2.com/causes/5-reasons-to-beware-of-nanoparticles-in-our-food-and-clothes.html
http://www.beyondpesticides.org/antibacterial/health/nano.php
http://www.sciencedaily.com/releases/2012/03/120314100416.htp
http://sciencenordic.com/silver-nanoparticles-can-cause-cellular-changes
See also : Nano-Silver Manufacture Patents
BULLETPROOF SPIDER SILK
http://www.kraiglabs.com/
http://www.livescience.com/46519-spider-silk-bulletproof-clothing.html
InnovationNewsDaily.com
January 04, 2012
New Worms' Silk Has Spider Strength
Francie Diep, InnovationNewsDaily Staff Writer
Think of it as softness blended with strength: One research team has genetically engineered a silkworm that spins cocoons composed of about 95 percent silkworm proteins and 5 percent spider silk proteins. The composite silk is significantly stronger than regular silkworm silk and, researchers hope, as easy to produce in large quantities as regular silk.
The research team reported on their results from two genetically engineered silkworms in this week’s issue of the journal Proceedings of the National Academy of Sciences.
Spider silk’s strength, lightness and flexibility make it an appealing material for sutures, artificial ligaments and tendons, bulletproof vests and more. So far, however, nobody has been able to harvest enough spider silk for practical use.
One problem is that people can’t farm spiders. The animals are territorial and, if kept in close quarters, have a tendency to eat each other. To get spider silk without cannibalizing spiders, several research teams have engineered cells and even goats to produce spider silk proteins. But that leads to a problem: how to spin that protein into large quantities of silken threads.
“All of those platforms allow for protein production, but then they have to find a way to transform those proteins to fibers,” said Donald Jarvis, a biologist at the University of Wyoming who led the research on the silkworm-spider blend.
Jarvis decided to recruit some docile natural silk-spinners to help him. “It seemed to me that the silkworm was the way to go because they naturally spin fibers,” he told InnovationNewsDaily.
Silkworms create large, fluffy cocoons, and for centuries people have grown them and harvested their silken wrappings to weave into fabric. Jarvis’ research team introduced a synthetic spider silk gene into silkworms’ silk-spinning glands. The gene included portions that code for elasticity and strength, and it was sandwiched between pieces of silkworm genetic material, which created a composite fiber that mixed the inserted gene’s material with the silkworm’s own product.
Jarvis’ team isn’t the first to get silkworms to spin part-spider silk, but it is the first to create a fiber significantly stronger than silkworm silk alone. The best fiber they created is about 48 percent stronger than regular silk and has about 61 percent the overall strength of dragline spider silk, which is the strongest silk that spiders make, said Randolph Lewis, a biologist at Utah State University who worked on the new composite. Spiders use dragline silk for the frameworks of their webs and for catching themselves when they fall, and it’s the type of silk that scientists are most eager to reproduce.
Though the new fiber isn’t as strong as 100 percent spider silk, it’s stronger than steel, Lewis said.
The team is now working on creating genetically engineered silkworms that can spin silk with a higher percentage of spider material, Jarvis said. That should mean an even stronger material that comes closer to mimicking spider draglines.
JARVIS' PATENTS
METHODS OF USING A BACTERIAL GLCNAC-6-P 2'-EPIMERASE TO PROMOTE SIALYLATION OF GLYCOCONJUGATES
WO2013019625
LEPIDOPTERAN INSECT N-ACETYLGLUCOSAMINIDASE GENES AND THEIR USE IN GLYCOENGINEERING
US2010279415
Production of Human Glycosylated Proteins in Silk Worm
US2010186099
INSECT CELL LINE FOR PRODUCTION OF RECOMBINANT GLYCOPROTEINS WITH SULFATED COMPLEX N-GLYCANS
US2009288178
Method and vector for the purification of foreign proteins
US5179007
Use of baculovirus early promoters for expression of foreign genes in stably transformed insect cells
US5077214
Modifying insect cell glycosylation pathways with baculovirus expression vectors
US6461863
Virus resistant plants having coat protein
US5736627
COMPOSITIONS AND METHODS FOR DELIVERY OF NUCLEIC ACIDS TO HEPATOCYTES
WO9806855
POROUS SUPPORT SYSTEM FOR THE IMMOBILIZATION OF IMMUNOASSAY COMPONENTS AND ASSAYS PERFORMED THEREWITH
WO9001167
WATER PURIFICATION BY ELECTRO-COAGULATION :
PATENTS
( espacenet.com )
( espacenet.com )
PROCESS FOR THE PURIFICATION OF WASTE WATER FROM BIOGENIC ELEMENTS
UA53298
TURBOELECTRIC COAGULATION APPARATUS
US2014138238
SYSTEM AND PROCESS FOR ELECTROCOAGULATION FLUID TREATMENT
CA2850413
PROCESS FOR TREATMENT OF WASTE WATER OF DOMESTIC SOLID GARBAGE DUMPS
UA45190
PROCESS FOR ADDITIONAL PURIFICATION OF WASTE WATER FROM PHOSPHORUS COMPOUNDS
UA45046
WATER PURIFICATION PROCESS FROM DISPERSE ADMIXTURES
UA86545
APPARATUS AND PROCESS FOR TREATMENT OF WATER
CA2849290
AIR FLOTATION AND ELECTROCOAGULATION SYSTEM
US2014116942
Fluid head height and foam/gas level control in electrocoagulation apparatus
US2014110262
APPARATUS AND METHOD FOR HARVESTING AND DEWATERING OF MICROALGAE BIOMASS
WO2014047726
REACTOR FOR ELECTROCOAGULATION AND AUTOTROPHIC DENITRIFICATION
KR101360374
Compound apparatus for processing waste water
TW201130751
System for optimizing performance of electrocoagulation tank using aluminum plate
TW201130743
METHOD AND SYSTEM FOR THE TREATMENT OF PRODUCED WATER
US2014054225
Moisture Transport System for Contact Electrocoagulation
US2014046317
ELECTROCOAGULATION REACTOR
US2014042020
Electrocoagulation for treating liquids
US2014027271
WASTEWATER TREATMENT APPARATUS AND METHOD
CA2837409
Rotary-drum high-voltage pulse electric flocculation device
CN103523869
Electrocoagulation apparatus having integrated clarifier and sludge control
US2014014505
Water treatment device with electrocoagulation machine reactor
CN203360223
Polyp removing machine and polyp removing method thereof
CN103462686
TREATMENT FOR MOLASSES SPENT WASH AND OTHER WASTEWATERS
US2013341267
Pretreatment method of organic silicon monomer production wastewater
CN103408181
Novel treatment device of pig farm wastewater
CN203295245
Spiral-flow type electrocoagulation device
CN103395867
Power supply connection adapter and water treatment device
CN203277792
Integrated multipole electrochemical water treatment equipment
CN203238128
Comprehensive compact unit for the treatment of effluents and/or sewage and system
CN103354803
DEVICE AND METHOD FOR SEWAGE WATER PROCESSING
RU2011139119
Method for treating chromium-containing wastewater by using continuous pulse electrocoagulation technology
CN103304075
Method for treating direct fast black G azo dye wastewater by using continuous pulse electrocoagulation technology
CN103304074
High-efficiency electrocoagulation device for sewage treatment
CN103304010
Method for treating phenol wastewater by using intermittent pulse electrocoagulation technology
CN103304009
ELECTROCOAGULATION REACTOR HAVING SEGMENTED INTERMEDIATE UNCHARGED PLATES
US2013233703
Method for heavy metal ion wastewater treatment based on outer circulation electrocoagulation technology
CN103288185
Particulate diffusion charge thickening method
CN103272696
Method For Using Electrocoagulation in Hydraulic Fracturing
US2013228331
PROCESS AND SYSTEM FOR THE TREATMENT OF INDUSTRIAL AND PETROLEUM REFINERY WASTEWATER
CA2796105
SYSTEM FOR TREATING ACID MINE DRAINAGE
KR20130058147
Recovery and treatment method for chemical nickel-plating waste water
TW201313618
METHOD AND SYSTEM FOR TREATING OILY WASTEWATER
CA2818329
PROCESS FOR SINGLE SYSTEM ELECTROCOAGULATION, MAGNETIC, CAVITATION AND FLOCCULATION (EMC/F) TREATMENT OF WATER AND WASTEWATER
US2013161262
Electrochemical sewage processing electrocoagulation machine power source pole changing power supply control cabinet
CN203012433
Electrochemistry catering sewage treatment system
CN202988893
Preprocessing device for waste water
CN202988810
Electrocoagulation equipment for wastewater treatment
CN202968218
NOVEL METHOD FOR TREATING WASTE WATERS
US2013134080
Electrocoagulation sewage treatment system
CN202953895
FLOCCULATION AND ELECTROLYSIS USING ELECTRICITY FLUORIDE CONCENTRATION OF NITROGEN-CONTAINING MERGE HANDLING
KR20130036630
TREATMENT OF WASTEWATER CONTAINING HIGH CONCENTRATIONS OF FLUORIDE
KR20130036629
SOLIDS REMOVAL SYSTEM AND METHOD
US2013126448
Efficient coking wastewater treatment method
CN103113000
PORTABLE ELECTRONIC WATER DISINFECTION DEVICE WITH REPLACEABLE TREATMENT CARTRIDGES
AU2012244232
PROCESS AND DEVICE FOR ELECTROCHEMICAL TREATMENT OF INDUSTRIAL WASTEWATER AND DRINKING WATER
WO2013144664
High-voltage pulse electrolytic oxidation based phosphorous removal device
CN202924857
High-voltage pulse electrolytic reduction based chromium removal device
CN202924856
Pipe-type high-wind speed double-charge region electrocoagulation device
CN202893504
Electrochemistry sewage treatment electrocoagulation machine electric source electrode change power supply control cabinet
CN103064333
Landfill leachate treatment technology by catalysis-anaerobic-electrocoagulation (AMC)
CN103011491
Electrocoagulation advanced treatment system and method for biochemically treating effluent of waste water of diosgenin saponins
CN102964013
SYSTEM FOR TREATING SLURRIES BY MEANS OF ELECTROCOAGULATION AND ELECTROOXIDATION
WO2013007847
Bipolar electrocoagulation shovel
CN202637107
METHOD AND APPARATUS FOR ELECTROCOAGULATION OF LIQUIDS
MY123321
Superfine particulate matter purifying device
CN102772971
Mobile water treatment system
CN202519116
Removing contaminants from liquid using electrocoagulation
GB2494299
METHOD FOR PURIFYING AQUEOUS STREAM, SYSTEM AND PROCESS FOR OIL RECOVERY AND PROCESS FOR RECYCLING POLYMER FLOOD
WO2012136064
Printing and dyeing wastewater zero-discharge reuse treatment method
CN102701500
ELECTROCOAGULATION FOR REMOVAL OF DISSOLVED ORGANICS FROM WATER
CA2788108
Treatment process of wastewater in coal chemical industry
CN102674634
SYSTEM AND METHOD OF PURIFYING AND RECYCLING OR DISCHARGING SEPTIC TANK EFFLUENT, GRAYWATER, RAINWATER AND STORMWATER
US2012228117
Mobile water treatment system
CN102642956
System and method for treating and distributing water
EP2567944
ELECTROCOAGULATION FOR TREATING LIQUIDS
CA2760605
Electrocoagulation water treatment device
CN202346857
ELECTROCOAGULATION REACTOR AND NOVEL PROCESS FOR REMOVING POLLUTANTS FROM UNDERGROUND WATER.
MX2010012606
Method and system for servicing a wellbore
US2012181014
Turboelectric coagulation apparatus
CN102596077
High-efficiency dissolved-oxygen flotation electrocoagulation sewage purification all-in-one machine
CN102557202
PROCESS AND APPARATUS FOR PRECIPITATING CATIONIC METAL HYDROXIDES AND THE RECOVERY OF SULFURIC ACID FROM ACIDIC SOLUTIONS
US2012156126
Electrocoagulation water treatment device
CN102503001
ELECTROCOAGULATION SYSTEM
US2012145647
ALL-ELECTRIC COAGULANT GENERATION SYSTEM
US2012145546
Waste water processing system and method thereof
CN102476885
Ultrasound, magnetic field, pulse electrocoagulation and membrane composite waste water treatment method, and apparatus thereof
CN102424495
Method for treating garbage leachate by multistage electrolysis
CN102424494
APPARATUS AND METHOD FOR WATER AND WASTEWATER TREATMENT USING ELECTROCOAGULATION
CA2755161
Electrocoagulation apparatus
EP2644573
Process for comprehensively treating sulfur dye waste water
CN102399040
Electrocoagulation-floatation machine
CN102398963
SOLIDS REMOVAL SYSTEM AND METHOD
CA2752963
Improved electrocoagulation treatment process
AU2011205140
Novel double-pole electrocoagulation device
CN102366333
Multi-contact electrocoagulation hemostasis device
CN102366332
WASTEWATER TREATMENT APPARATUS AND METHOD
WO2012024759
ELECTROCOAGULATION DEVICE WITH LIMITED HEAT DAMAGE
WO2012116957
Device for treating high-chroma refractory organic waste water
CN102358654
Treatment method of chemical nickel-plating wastewater
CN102329030
Method for removing fluorin ions in water through electrocoagulation-adsorption
CN102329029
High-efficiency electrocoagulation processor and intelligent electric control device thereof
CN102328973
Solids Removal System and Method
US2012006762
Resource utilization device for restaurant wastewater
CN202080974
Electrocoagulation air floatation equipment
CN202072570
AN ELECTROCOAGULATION TREATMENT SYSTEM
WO2012059905
System and process for treating waste water with electrochemical method
CN102249465
Multifunctional electrocoagulation and electrosection forceps
CN202036313
Power type waste water treatment system
TW201113224
METHOD AND APPARATUS FOR ELECTROCOAGULATION
US2011266203
Water treatment apparatus
TW200829515
Papermaking wastewater treatment method
TW200829516
Improved advanced oxidation process (AOP) and system for wastewater treatment
TW200811063
Ultrafine dust electrocoagulation device
CN202006137
Marine wastewater treatment
CN102215926
Resource utilization device and method of restaurant wastewater
CN102211840
SOLIDS REMOVAL SYSTEM AND METHOD
US2011233144
Process method for combining physical-chemical treatment and biochemical treatment for reinjection water with oil-field produced water
CN102180566
Device and method for processing restaurant wastewater
CN102145967
Movable type catering waste water treatment equipment
CN102139978
Fully automatic electrocoagulation wastewater treatment equipment
TWM360878
METHOD AND APPARATUS FOR TREATMENT OF CONTAMINATED LIQUID
US2011198237
Electrocoagulation treatment process
US2011180422
System for electrocoagulatively removing contaminants from contaminated water
CN102119129
HIGH-THROUGHPUT CAVITATION AND ELECTROCOAGULATION APPARATUS
WO2011079276
High-efficient electrocoagulation reactor capable of adjusting pitches among electrodes
CN201882958
Method for treating low-permeability oilfield reinjection water
CN102107998
Electrocoagulation device and method for sewage treatment
CN102101709
Treatment system and method for industrial waste water with high concentration of salt
CN102092887
Application method of high-property activated carbon fibers in treatment of industrial waster water by electrocoagulation
CN102092821
Coal bed gas product processing method and device
CN102079600
ELECTROCOAGULATION SYSTEM FOR TREATING INDUSTRIAL WASTEWATER.
MX2009008837
APPARATUS FOR TREATING WASTE WATER EFFLUENT WITH ELECTROCOAGULATION FLOATING TYPE AND METHOD FOR TREATING WASTE WATER EFFLUENT USING THE SAME
KR101030075
Device for treating waste water by electrocoagulation
CN201809210
Combined electrolysis equipment for treating emulsified oil wastewater
CN201793449
Combination cross-flow air floatation water treatment device based on electrocoagulation and secondary filtering
CN201785276
Waste water electrolysis treatment system
CN201785224
Equipment for treating garbage pressure filtrate
CN201777959
Cross flow type air floating device based on electrocoagulation
CN201777270
Treatment method for high-concentration sulfur-containing caustic sludge wastewater from oil refinery
CN101985379
An electrocoagulation cell
CN101980967
Photoelectric materialized water treatment system
CN201746420
Sewage purification device adopting electrocoagulation membrane separation method
CN201694916
Electrocoagulation sedimentation pond
CN101928053
An electrocoagulation apparatus with corrosion protection for water purification
GB2484699
WATER TREATMENT AND REUSE SYSTEM
US2010307975
Pretreatment device for coking wastewater recycling and combined treatment system
CN201665596
Surface-cooling, pre-charging and pre-dedusting equipment improved from humidifying tower
CN201644220
Wastewater electrolytic treatment system
CN101891324
Treatment system and method of coking wastewater
CN101885566
CHEMICAL AND ELECTROLYSIS RECTOR
KR20100098488
Processing method of tertiary oil recovery produced water containing polyacrylamide
CN101863576
METHOD FOR ELECTROCOAGULATION OF LIQUIDS
US2010252447
APPARATUS FOR PURIFYING LIQUID, METHOD OF WASHING HOLLOW-FIBRE FILTER AND APPLICATION OF METHOD OF WASHING HOLLOW-FIBRE FILTER
RU2009106887
THE METHOD OF REMOVING T-P FROM SEWAGE TREATMENT PLANT BY ELECTROCOAGULATION AND WITHDRAWAL POSPHATE COMPOUND
KR100975031
METHOD OF ELECTROCHEMICAL PURIFICATION OF MEAT-PROCESSING PLANT SEWAGE
RU2008144068
Treatment process for sewage in oil field
CN101786769
Method and device for pretreatment of high CODCr sewage by electrocoagulation-diatomite technology
CN101774714
Method for recycling and treating coking wastewater
CN101723549
System for recycling and treating coking wastewater
CN101723548
Method for treating concentrated water produced by coking wastewater recycling process
CN101723533
System for treating concentrated water produced by coking wastewater recycling process
CN101723532
ARSENIC REMOVAL BY ELECTROCOAGULATION
MX2008013697
Situ system and method for treating an oil and gas well drilling fluid
US7731854 (B1) 2010-06-08
METHOD AND APPARATUS FOR TREATAMENT OF CONTAMINATED LIQUID
US2010126932
332. HOSPITAL WASTEWATER TREATMENT APPARATUS USING ELECTRO-COAGULATION PROCESS
KR20100032941
MARINE WASTEWATER TREATMENT
US2010122913
REMOVAL OF CONTAMINANTS FROM A FLUID
US2010116650
ELECTRODE CELL DESIGN FOR USE IN ELECTROCOAGULATION FLUID TREATMENT
WO2010036844
Combined processing technique of garbage percolates
CN101671090
Method for treating water from micro-polluted water source
CN101643256
Method and device for treating dye wastewater employing periodic reverse electrocoagulation
CN101638257
METHOD FRO RECOVERING PRECIOUS METALS BY ELECTROCOAGULATION.
MX2009007628
Method for treating phosphoric wastewater through ozone-enhanced electrocoagulation
CN101618905
Aquaculture water purifying device
CN201367380
Method and device for processing pharmaceutical wastewater by pulse electrocoagulation-MBR
CN101560040
SEWAGE AND WASTER WATER TREATMENT USING THE ELECTRO COAGULATION AND ELECTRO PRECIPITATION
KR20090057772
METHOD AND APPARATUS FOR ELECTROCOAGULATION OF LIQUIDS
US2009173638
Sewage treatment method for fluorite concentration plant
CN101468857
WASTEWATER TREATMENT PLANT
US2009166296
Ultrasonic electrocoagulation-film filtering combined water treating device
CN201240964
High-frequency pulse electrocoagulation
CN201240902
Wastewater purification method using an electrocoagulation cell
NZ546755
TREATMENT PROCESS AND SYSTEM FOR WASTEWATER, PROCESS WATERS, AND PRODUCED WATERS APPLICATIONS
US2009107915
Water treatment process and equipment
CN101353193
ELECTROCOAGULATION REACTOR AND WATER TREATMENT SYSTEM AND METHOD
WO2009009465
ELECTROCOAGULATION REACTOR AND WATER TREATMENT SYSTEM AND METHOD
US2009008269
Electrocoagulation sea water pretreatment
CN101323469
Device for treating oil extraction waste water by coagulation-electrocoagulation-ultrafiltration method and the method
CN101306895
Electroplating sewerage advanced treatment process
CN101302073
Method and apparatus for electrocoagulation of liquids.
ZA9902479
APPARATUS AND METHOD FOR MANURE RECLAMATION
WO2006138383
ELECTROCOAGULATION SYSTEM
WO2004089832
Electrocoagulation chamber and method
US6613217
Process and apparatus for electrocoagulative treatment of industrial waste water
US5928493
System and method for removing deep sub-micron particles from water
US2005045534
Process and apparatus for electrocoagulative treatment of industrial waste water
US2002040855
Method and Apparatus for Decontamination of Fluid with One or More High Purity Electrodes
US2008185293
Method and apparatus for purifying and compacting solid wastes
US5232584
Electrocoagulation waste water batch tank treatment system
US7258800
Process for electrocoagulating waste fluids
US2002020631
Electrocoagulation Reaction Chamber
US2006151337
Water and wastewater treatment system
US5240600
Method and apparatus for removing dissolved metals from wastewater by electrocoagulation
US2002185446
Sequencing batch liquid treatment
US5354458
Thin film electrocoagulation for removal for contaminants from liquid
US5271814
Water treatment reactor for simultaneous electrocoagulation and advanced oxidation processes
US2005224338
Apparatus for purifying wastewater
US2001004063
Gas dissolving and releasing liquid treatment system
US5167806
High pressure process and apparatus for the electrocoagulative treatment of aqueous and viscous fluids
US2004140218
METHODS OF PURIFYING BIODIESEL FUELS
US2008202021
Bilge water reclamation system and process
US2004060876
Fluid Purification Methods and Devices
US2008087603
Waste water treatment method and apparatus
US6358398
Process and apparatus for electrocoagulative treatment of industrial waste water
US6294061
Electrocoagulation system
US2006096853
Electrocoagulation system for removing pollutants from wastewater
US3969245
Method for cleaning polluted water
US2005218081
Contaminant removal apparatus and installation method
US2005247571
Novel cells and electrodes for electrocoagulation treatment of wastewater
US2004238365
Leachate and wastewater remediation system
US2003173300
Apparatus for electrochemical purification of contaminated liquids
US4414091
Apparatus for electrochemical purification of contaminated liquids
US4338178
Electrocoagulation and polymeric suspended solids reduction
US2007036881
Apparatus for electrochemical purification of contaminated liquids
US4349431
Method and apparatus for electrochemical purification of contaminated liquids
US4295946
Apparatus for electrochemical purification of contaminated liquids
US4321125
Highly conductive liquid media electrocoagulation
US5587057
Apparatus for electrochemical purification of contaminated liquids
US4349430
Apparatus and process for treating effluents
US2005230321
Advanced Electro-Coagulation Device And Process Of Using The Same For Wastewater Treatment
US2008223731
Method and apparatus for electrocoagulation of liquids
US2002088710
High volume electrolytic water treatment system and process for treating wastewater
US2003136686
SSNOVEL CELLS AND ELECTRODES FOR ELECTROCOAGULATION TREATMENT OF WASTEWATER
WO0244092
METHOD FOR PURIFICATION OF WASTE WATERS AND SLUDGE TREATMENT
UA28030
APPARATUS FOR ELECTROCHEMICAL PURIFICATION OF WASTEWATER
UA17651
Cleaning structure for electrocoagulation device
TWM243277
Water treatment reactor for simultaneous electrocoagulation and advanced oxidation processes
TWI257920
Method and apparatus for removing nanoparticles and emulsion droplets from aqueous solutions by simultaneous electrocoagulation and electrofiltration
TWI229656
METHOD AND DEVICE FOR PURIFICATION OF WASTEWATER
WO9219543
DEVICE FOR SEWAGE TREATMENT BY ELECTROCOAGULATION
RU1792922
METHOD OF ELECTROCOAGULATION PURIFYING OF WASTE WATER
SU1548159
METHOD OF AUTOMATIC CONTROL OF WASTE WATER ELECTROCOAGULATION CLEANING CONTINUOUS PROCESS
SU1116022
BOCKRIS, et al. : CO2 Catalyzed
Plasmolysis of Water
Photos provided by Dr. Vladislav Rogozov
So here are the facts: it happened during 6th Soviet Antarctic Expedition at Novolazarevskaya Station. The patient was the only physician on station, so the assistant was a mechanic. It was on April 30, 1961. The operation took 2 hours. He positioned himself so that he could see his own body using a mirror when doing the surgery - he made a 12 cm cut through which he found the appendix. After 5 days the doctor felt good, and after 7 days he removed the wires which had been used to sew up the body. His name: Leonid Rogozov. He published a short note about this in the Soviet Antarctic Expedition Information Bulletin, no. 37, pp. 42-44, 1962.
The above information was provided a while ago by Alex Zaitsev, the Russian exchange scientist and friend that I wintered with at Pole in 1977. When the bulletins were translated into English, they were compiled in volumes of ten issues; numbers 31-40 were put in Volume 4, so the English reference for Dr. Rogozov's note is Rogozov KI: Self-operation. Soviet Antarctic Expedition Information Bulletin 4:223, 1964, and here is my copy.
Novolazarevskaya is at 70°S 11°E, set up in 1960-61 on rock (the Shirmacher Oasis) in Queen Maud Land, 50 miles inland from the ice edge. It was closed for a bit in 1992...but more recently it is more commonly known as Novo...the blue ice runway also used by tourist operations is a few miles to the southwest.
instruments used in the surgeryThe Russian State Museum of the Arctic and Antarctic in St. Petersburg, surprisingly, has an exhibit on the self-appendectomy...featuring another different photo of the operation as well as some of the surgical instruments used (left). The English translation of the placard:
Surgical Instruments -- By which the operation was carried out by surgeon Rogozov on himself (because of a suppurative appendix) at station Novolazarevskaya 04.30.61.
Rogozov, became ill on 29 April. He came to the decision to make the operation on 30 April at 22 hours and 15 minutes. Rogozov, using mirror began operation, which lasted 2 hours. Equipment used in the operation was normal, performed in the semi-sitting position. The operation was carried out under local anesthesia. Assisting the doctor doctor was the Meteorologist and Chief Engineer Mechanic. On 7 May the patient was satisfied and removed the stitches...
http://www.livescience.com/46411-free-will-is-background-noise.htmlhttp://www.southpolestation.com/trivia/igy1/appendix.html
That Self-Appendectomy
Photos provided by Dr. Vladislav Rogozov
So here are the facts: it happened during 6th Soviet Antarctic Expedition at Novolazarevskaya Station. The patient was the only physician on station, so the assistant was a mechanic. It was on April 30, 1961. The operation took 2 hours. He positioned himself so that he could see his own body using a mirror when doing the surgery - he made a 12 cm cut through which he found the appendix. After 5 days the doctor felt good, and after 7 days he removed the wires which had been used to sew up the body. His name: Leonid Rogozov. He published a short note about this in the Soviet Antarctic Expedition Information Bulletin, no. 37, pp. 42-44, 1962.
The above information was provided a while ago by Alex Zaitsev, the Russian exchange scientist and friend that I wintered with at Pole in 1977. When the bulletins were translated into English, they were compiled in volumes of ten issues; numbers 31-40 were put in Volume 4, so the English reference for Dr. Rogozov's note is Rogozov KI: Self-operation. Soviet Antarctic Expedition Information Bulletin 4:223, 1964, and here is my copy.
Novolazarevskaya is at 70°S 11°E, set up in 1960-61 on rock (the Shirmacher Oasis) in Queen Maud Land, 50 miles inland from the ice edge. It was closed for a bit in 1992...but more recently it is more commonly known as Novo...the blue ice runway also used by tourist operations is a few miles to the southwest.
instruments used in the surgeryThe Russian State Museum of the Arctic and Antarctic in St. Petersburg, surprisingly, has an exhibit on the self-appendectomy...featuring another different photo of the operation as well as some of the surgical instruments used (left). The English translation of the placard:
Surgical Instruments -- By which the operation was carried out by surgeon Rogozov on himself (because of a suppurative appendix) at station Novolazarevskaya 04.30.61.
Rogozov, became ill on 29 April. He came to the decision to make the operation on 30 April at 22 hours and 15 minutes. Rogozov, using mirror began operation, which lasted 2 hours. Equipment used in the operation was normal, performed in the semi-sitting position. The operation was carried out under local anesthesia. Assisting the doctor doctor was the Meteorologist and Chief Engineer Mechanic. On 7 May the patient was satisfied and removed the stitches...
Free Will
Free Will May Just Be the Brain's 'Background Noise,' Scientists Say
It's a question that has plagued philosophers and scientists for thousands of years: Is free will an illusion?Now, a new study suggests that free will may arise from a hidden signal buried in the "background noise" of chaotic electrical activity in the brain, and that this activity occurs almost a second before people consciously decide to do something.
Though "purposeful intentions, desires and goals drive our decisions in a linear cause-and-effect kind of way, our finding shows that our decisions are also influenced by neural noise within any given moment," study co-author Jesse Bengson, a neuroscientist at the University of California, Davis, wrote in an email to Live Science. "This random firing, or noise, may even be the carrier upon which our consciousness rides, in the same way that radio static is used to carry a radio station."
This background noise may allow people to respond creatively to novel situations, and it may even give human behavior the "flavor of free will," Bengson said.
Predetermined or random
Sir Isaac Newton's laws of classical mechanics suggested the universe was deterministic, with an inevitable effect for every cause. By Newtonian logic, a "freely" made decision is completely predetermined by the actions that precede it.
But quantum physics revealed that subatomic particles' behavior is inherently unpredictable. As a result, physical forces like gravity and electromagnetism can't completely dictate the future based on past events, thus leaving a tiny window for free will to operate through the random behavior of subatomic particles.
Still, many philosophers doubted that the random behavior of miniscule particles could translate to free will, because quantum effects don't hold much sway at larger scales.
Experiments performed in the 1970s also raised doubts about human volition. Those studies, conducted by the late neuroscientist Benjamin Libet, revealed that the region of the brain that plans and executes movement, called the motor cortex, fired prior to people's decision to press a button, suggesting this part of the brain "makes up its mind" before peoples' conscious decision making kicks in.
Hidden signal?
To understand more about conscious decision making, Bengson's team used electroencephalography (EEG) to measure the brain waves of 19 undergraduates as they looked at a screen and were cued to make a random decision about whether to look right or left.
When people made their decision, a characteristic signal registered that choice as a wave of electrical activity that spread across specific brain regions.
But in a fascinating twist, other electrical activity emanating from the back of the head predicted people's decisions up to 800 milliseconds before the signature of conscious decision making emerged.
This brain activity wasn't strictly a signal at all — it was "noise," part of the brain's omnipresent and seemingly random electrical firing. In fact, neuroscientists usually consider this background noise meaningless and subtract it when trying to figure out the brain response to a specific task, said Rick Addante, a neuroscientist at the University of Texas at Dallas who was not involved in the research.
In other words, some hidden signal in the background noise of the brain seemed to determine people's conscious decisions before they made them.
"That's what's wild about it; it's not all noise," Addante told Live Science. "The question then becomes, what is it, and what is the informationthat it contains?"
Open question
The new study doesn't prove or disprove free will, Addante said.
"If there's something else occurring before our conscious awareness that's contributing to our decision, that raises the question about the extent of our free will," Addante said. On the other hand, the findings might open the door to free will by suggesting it rides on, but isn't quite the same as, the random background noise in our brains, he said.
But Ali Mazaheri, a neuroscientist at the University of Amsterdam in the Netherlands, sees the results as a blow to true free will.
The findings suggest that previous biases in the firing of the brain's sensory processing systems add up, leading people to decisions that the conscious brain later follows, said Mazaheri, who was not involved in the study.
Useful illusion?
But if free will is an illusion, why does it feel so real?
Though that's still a mystery, one theory is that life would be too depressing without the illusion of choice, making it hard for humans to survive and reproduce.
"The idea is that you have the illusion of free will as an artifact to be able to get through life," Mazaheri told Live Science.
R & D @ Rex Research
Here @ Rex Research, our brainiacs are
developing a monster robot to defeat Iron Man and the Muslim
idiot army ISIS and the American mercenary cunt army
ISIS.
Below : An out-of-control Gen-V prototype --
Below : An out-of-control Gen-V prototype --
Imagineering with techno-porn :
Resulting in : The Anti-Masturbation
Codpiece --
Support the Fukushima Wimps
Despite their lives being shattered by the
meltdowns at Fukushima Daiichi, the obedient, dumbed-down
dupes of the Japanese pseudo-government continue to keep
their mealy mouths shut and eat radioactive shit.
How sadly pathetic and stupid of
them -- let's waste pity on the cowards, okay ? Here's how
you can help ! Buy these wonderful new economic
wonderments from Japan and help maintain corporate rulership
of your miserable excuse for a half-life !
https://www.facebook.com/onlinesupa
http://www.youtube.com/watch?v=kP3Rrreryxo
Jun 15, 2010
It needs a little power -- as little as 6 volts DC -- to start up the energy. Ater that the engine will generate electric power and not require 6 volt anymore. During the generating electricity the engine become hot -- about 120*C. -- so we are developing the next prototype to ventilate the heat. This 1st prototype can generate AC electricity 220 volt / 1000 watts. Have to stop the engine every 3 hours and wait about 5 minutes to restarting again.
In July 16, 2011 I just built a new version of electron generator model FE-88. It use battery size AA x 8 pcs to warm up the system.
https://www.facebook.com/onlinesupa
http://www.youtube.com/watch?v=kP3Rrreryxo
Jun 15, 2010
Almost FREE electricity with
Boondee Electron generator
Electron generator was invented by the inventor of Boondee Workshop
Electron generator was invented by the inventor of Boondee Workshop
It needs a little power -- as little as 6 volts DC -- to start up the energy. Ater that the engine will generate electric power and not require 6 volt anymore. During the generating electricity the engine become hot -- about 120*C. -- so we are developing the next prototype to ventilate the heat. This 1st prototype can generate AC electricity 220 volt / 1000 watts. Have to stop the engine every 3 hours and wait about 5 minutes to restarting again.
In July 16, 2011 I just built a new version of electron generator model FE-88. It use battery size AA x 8 pcs to warm up the system.